Body and Mind (BMMJ) 10-K 18 Nov 21 2021 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Jul. 31, 2021	Nov. 18, 2021	Feb. 28, 2021
Cover [Abstract]
Entity Registrant Name	BODY AND MIND INC.
Entity Central Index Key	0001715611
Document Type	10-K
Amendment Flag	false
Entity Voluntary Filers	No
Current Fiscal Year End Date	--07-31
Entity Well Known Seasoned Issuer	No
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity Current Reporting Status	Yes
Document Period End Date	Jul. 31, 2021
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2021
Entity Ex Transition Period	true
Entity Common Stock Shares Outstanding		110,621,308
Entity Public Float			$ 58,628,685
Document Annual Report	true
Entity Interactive Data Current	Yes
Document Transition Report	false
Entity File Number	000-55940
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	98-1319227
Entity Address Address Line 1	750 – 1095 West Pender Street
Entity Address City Or Town	Vancouver
Entity Address Country	CA
Entity Address Postal Zip Code	V6E 2M6
City Area Code	800
Local Phone Number	361-6312
Security 12b Title	Common Shares, $0.0001 par value

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jul. 31, 2021	Jul. 31, 2020
Current
Cash	$ 7,374,194	$ 1,352,130
Amounts receivable	1,544,957	972,705
Interest receivable on convertible loan (Note 6)	150,000	78,000
Prepaids	413,246	138,016
Inventory (Note 5)	2,936,156	1,769,837
Convertible loan receivable (Note 6)	1,648,816	1,290,263
Other loan receivable (Note 7)	239,834	0
Total Current Assets	14,307,203	5,600,951
Deposit	470,546	0
Investment in NMG Ohio LLC (Note 8)	0	3,161,240
Loan receivable from NMG Ohio LLC (Note 8)	891,279	0
Investment in and advances to GLDH (Note 9)	0	8,910,854
Property and Equipment net (Note 10)	4,893,790	4,599,204
Operating lease right-of-use assets (Note 15)	2,539,023	2,133,815
Brand and Licenses net (Note 12)	19,855,068	11,757,483
Goodwill (Note 12)	5,168,902	2,635,721
TOTAL ASSETS	48,125,811	38,799,268
Current
Accounts payable	1,686,376	753,846
Accrued liabilities	105,538	30,712
Income taxes payable	3,832,078	1,609,479
Due to related parties (Note 13)	52,074	52,937
Loan payable (Note 14)	16,874	0
Current portion of operating lease liabilities (Note 15)	761,415	362,688
Total Current Liabilities	6,454,355	2,809,662
Long-term operating Lease Liabilities (Note 15)	2,323,525	1,806,212
Loan payable (Note 14) 123	4,798,871	0
Loan Payable to NMG Ohio LLC (Note 8)	0	466,495
Deferred Tax Liability	198,339	412,450
TOTAL LIABILITIES	13,775,090	5,494,819
STOCKHOLDERS' EQUITY
Capital Stock- Statement 3 (Note 16) Authorized: 900,000,000 Common Shares - Par Value $0.0001 Issued and Outstanding: 109,077,778 (2020 - 107,513,812) Common Shares	10,907	10,751
Additional Paid-in Capital	50,312,013	47,665,678
Shares to be Issued	0	19,703
Other Comprehensive Income	1,127,713	731,768
Accumulated Deficit	(17,126,510)	(14,865,608)
TOTAL STOCKHOLDERS' EQUITY ATTRIBUTABLE TO BAM STOCKHOLDERS	34,324,123	33,562,292
NON-CONTROLLING INTEREST	26,598	(257,843)
TOTAL EQUITY	34,350,721	33,304,449
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 48,125,811	$ 38,799,268

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Jul. 31, 2021	Jul. 31, 2020
Consolidated Balance Sheets
Common stock, shares authorized	900,000,000	900,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common Stock, Shares, Outstanding	109,077,778	107,513,812
Common stock, shares issued	109,077,778	107,513,812

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Consolidated Statements of Operations
Sales	$ 26,900,869	$ 6,232,521
Sales tax	(1,200,845)	(945,232)
Cost of sales	(13,709,815)	(3,778,898)
Total Sales	11,990,209	1,508,391
Operating Expenses
Accounting and legal	973,594	676,935
Bad debt expense	0	54,047
Business development	282,865	449,949
Consulting fees	537,760	565,472
Depreciation	1,457,550	112,025
Insurance	170,520	113,523
Lease expense	431,427	219,384
Licenses, utilities and office administration	2,462,815	1,090,215
Management fees (Note 13)	405,134	449,877
Regulatory, filing and transfer agent fees	61,415	65,997
Rent	186,822	275,102
Salaries and wages	3,400,472	1,589,037
Stock-based compensation (Note 16)	975,555	1,278,282
Travel	56,953	115,354
Total Operating Expenses	(11,402,882)	(7,055,199)
Net Operating Income (Loss)	587,327	(5,546,808)
Other Income (Expenses)
Foreign exchange, net	235	5,388
Interest expense	(53,394)	(132,718)
Interest income	163,558	1,119,503
Loss on impairment (Notes 8 and 9)	(592,547)	1,008
Loss on settlement (Note 21)	0	(331,743)
Other income (expenses)	(95,416)	26,046
Gain on bargain purchase (Note 11)	167,266	0
Equity-method investement change from earnings (Note 8)	13,219	397,119
Net Income (Loss) Before Income Tax	190,248	(4,464,221)
Income tax expense	(2,166,709)	(134,168)
Net Loss	(1,976,461)	(4,598,389)
Other Comprehensive Income (Loss)
Foreign currency translation adjustment	395,945	(95,546)
Comprehensive Loss	(1,580,516)	(4,693,935)
Net income (loss) attributable to:
Body and Mind Inc.	(2,260,902)	(4,340,546)
Non-controlling interest	284,441	(257,843)
Comprehensive income (loss) attributable to:
Body and Mind Inc.	(1,864,957)	(4,436,092)
Non-controlling interest	$ 284,441	$ (257,843)
Loss per Share - Basic and Diluted	$ (0.02)	$ (0.04)
Weighted Average Number of Shares Outstanding	108,463,019	102,644,757

Condensed Consolidated Statemen

Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Total	Common Stock	Additional Paid-In Capital	Shares To Be Issued [Member]	Other Comprehensive Income [Member]	Retained Earnings (Accumulated Deficit)	Noncontrolling Interest
Balance, shares at Jul. 31, 2019		97,279,891
Balance, amount at Jul. 31, 2019	$ 33,196,203	$ 9,728	$ 41,765,408	$ 1,118,815	$ 827,314	$ (10,525,062)	$ 0
Common stock issued in acquisition of GLDH (Note 9), shares		7,018,115
Common stock issued in acquisition of GLDH (Note 9), amount	4,094,957	$ 702	4,094,255	0	0	0	0
Conversion of debt, shares		2,909,091
Conversion of debt, amount	0	$ 291	1,196,793	(1,197,084)	0	0	0
Exercise of warrants (Note 16), shares		165,715
Exercise of warrants (Note 16), amount	90,839	$ 16	90,823	0	0	0	0
Escrow release, shares		141,000
Escrow release, amount	0	$ 14	33,533	(33,547)	0	0	0
Share payment reduction related to investment in GLDH (Note 9)	(793,416)	0	(793,416)	0	0	0	0
Stock-based compensation (Note 16)	1,278,282	0	1,278,282	0	0	0	0
Accretion and interest on convertible debt	131,519	0	0	131,519	0	0	0
Foreign currency translation adjustment	(95,546)	0	0	0	(95,546)	0	0
Loss for the year	(4,598,389)	$ 0	0	0	0	(4,340,546)	(257,843)
Balance, shares at Jul. 31, 2020		107,513,812
Balance, amount at Jul. 31, 2020	33,304,449	$ 10,751	47,665,678	19,703	731,768	(14,865,608)	(257,843)
Escrow release, shares		70,500
Escrow release, amount	0	$ 7	19,696	(19,703)	0	0	0
Stock-based compensation (Note 16)	975,555	$ 0	975,555	0
Foreign currency translation adjustment	395,945				395,945
Loss for the year	(1,976,461)					(2,260,902)	284,441
Common stock issued in acquisition of NMG Ohio LLC (Note 8), shares		793,466
Common stock issued in acquisition of NMG Ohio LLC (Note 8), amount	297,042	$ 79	296,963	0	0	0	0
Exercise of options (Note 16), shares		700,000
Exercise of options (Note 16), amount	317,045	$ 70	316,975	0	0	0	0
Warrants issued with debt (Notes 14)	1,037,146	$ 0	1,037,146	$ 0	0	0	0
Balance, shares at Jul. 31, 2021		109,077,778
Balance, amount at Jul. 31, 2021	$ 34,350,721	$ 10,907	$ 50,312,013		$ 1,127,713	$ (17,126,510)	$ 26,598

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Cash Resources Provided By (Used In) Operating Activities
Net loss for the year	$ (1,976,461)	$ (4,598,389)
Items not affecting cash:
Accrued interest and accretion	15,474	131,519
Accrued interest income	(72,000)	(1,029,503)
Advances to GLDH expensed during the year	0	680,018
Amortization of licenses	1,122,415	78,025
Amortization of ROU assets	431,427	123,240
Bargain purchase	(167,266)	0
Deferred tax expense	(214,110)	(1,303,670)
Depreciation	765,857	378,105
Foreign exchange	(236)	196,621
Equity-method investment change from earnings	(13,219)	(397,119)
Impairment loss	592,747	0
Loss on settlement	0	331,743
Stock-based compensation	975,555	1,278,282
Write off of amounts receivable	0	1,008
Write off of inventory	0	208,096
Amounts receivable and prepaids	(528,364)	(23,077)
Interest receivable on convertible loan	0	51,000
Inventory	(809,491)	(587,514)
Trade payables and accrued liabilities	(194,328)	(290,060)
Income taxes payable	1,798,668	1,370,121
Due to related parties	(3,439)	39,985
Lease liabilities	(536,985)	(88,155)
Loan to NMG Ohio LLC	(891,279)	(112,869)
Loan from NMG Ohio LLC	0	1,252,429
Cash provided by (used in) operating activities	294,965	(2,310,164)
Investing Activities
Investment in NMG Ohio, LLC, net of cash received	(136,325)	0
Investment in GLDH, net of cash received	65,340	(2,893,609)
Other investments	0	(334,348)
Purchase of property and equipment	(402,459)	(871,720)
Convertible loan receivable	(358,553)	(1,238,038)
Cash used in investing activities	(831,997)	(5,337,715)
Financing Activities
Issuance of shares, net of share issue costs	313,415	90,839
Proceeds from loans payable, net	5,852,311	0
Cash provided by financing activities	6,165,726	90,839
Effect of exchange rate changes on cash	393,370	(95,546)
Net Increase (Decrease) in Cash	6,022,064	(7,652,586)
Cash- Beginning of Year	1,352,130	9,004,716
Cash- End of Year	$ 7,374,194	$ 1,352,130

Nature and Continuance of Opera

Nature and Continuance of Operations	12 Months Ended
	Jul. 31, 2021
Nature and Continuance of Operations
1. Nature And Continuance of Operations	1. Nature and Continuance of Operations Body and Mind Inc. (the “Company”) was incorporated on 5 November 1998 in the State of Delaware, USA, under the name Concept Development Group, Inc. In May 2004, the Company acquired 100% of Vocalscape, Inc. and changed its name to Vocalscape, Inc. On October 28, 2005, the Company changed its name to Nevstar Precious Metals Inc. On October 23, 2008, the Company changed its name to Deploy Technologies Inc. (“Deploy Tech”) and, on September 15, 2010, the Company incorporated a wholly-owned subsidiary, Deploy Acquisition Corp. (“Deploy”) under the laws of the State of Nevada, USA. On September 17, 2010, the Company merged with and into Deploy under the laws of the State of Nevada. Deploy, as the surviving corporation of the merger, assumed all the assets, obligations and commitments of Deploy Tech, and we were effectively re-domiciled in the State of Nevada. Upon the completion of the merger, Deploy assumed the name “Deploy Technologies Inc.”, and all of the issued and outstanding common stock of Deploy Tech was automatically converted into and became Deploy’s issued and outstanding common stock. On 14 November 2017, the Company acquired Nevada Medical Group, LLC (“NMG”) and changed its name to Body and Mind Inc. The Company is now a supplier and grower of medical and recreational cannabis in the state of Nevada, and has retail operations in California, Ohio, and Arkansas. Principles of Consolidation These consolidated financial statements include the financial statements of the Company and its subsidiaries as follows: Name Jurisdiction Ownership Date of acquisition or formation DEP Nevada Inc. (“DEP Nevada”) Nevada, USA 100 % 10 August 2017 Nevada Medical Group LLC (“NMG”) Nevada, USA 100 % 14 November 2017 NMG Long Beach LLC California, USA 100 % 18 December 2018 NMG Cathedral City LLC California, USA 100 % 4 January 2019 NMG San Diego LLC California, USA 60 % 30 January 2019 NMG OH 1, LLC Ohio, USA 100 % 30 January 2020 NMG MI 1, Inc. Michigan, USA 100 % 24 June 2021 NMG MI C1 Inc. Michigan, USA 100 % 24 June 2021 NMG MI P1 Inc. Michigan, USA 100 % 24 June 2021 All inter-company transactions and balances are eliminated upon consolidation. These consolidated financial statements include the following investments accounted for using the equity method of accounting: Name Jurisdiction Ownership Date of acquisition or formation NMG Ohio LLC Ohio, USA 30 % 27 April 2017

Recent Accounting Pronouncement

Recent Accounting Pronouncements	12 Months Ended
	Jul. 31, 2021
Nature and Continuance of Operations
2. Recent Accounting Pronouncements	2. Recent Accounting Pronouncements In June 2016, the FASB issued ASU No. 2016-13 “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” which requires the measurement and recognition of expected credit losses for financial assets held at amortized cost. ASU 2016-13 replaces the existing incurred loss impairment model with an expected loss methodology, which will result in more timely recognition of credit losses. ASU 2016-13 is effective for annual reporting periods, and interim periods within those years beginning after December 15, 2022. The Company does not anticipate this amendment to have a significant impact on the consolidated financial statements. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) – Simplifying the Accounting for Income Taxes. ASU 2019-12 removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. ASU 2019-12 is effective for annual and interim periods beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the effect of adopting this ASU on the Company’s consolidated financial statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers Revenue from Contracts with Customers The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the consolidated financial position, statements of operations and cash flows.

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Jul. 31, 2021
Significant Accounting Policies
3. Significant Accounting Policies	3. Significant Accounting Policies The following is a summary of significant accounting policies used in the preparation of these consolidated financial statements. Reclassification Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of current period financial statements. These reclassifications had no effect on the previously reported net loss. Basis of presentation These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and are expressed in U.S. dollars. The Company’s fiscal year end is 31 July. Amounts receivable Amounts receivable represents amounts owed from customers for sale of medical and recreational cannabis and sales tax recoverable. Amounts are presented net of the allowance for doubtful accounts, which represents the Company’s best estimate of the amount of probable credit losses in the existing accounts receivable balance. The Company determines the allowance for doubtful accounts based on historical experience and current economic conditions. The Company reviews the adequacy of its allowance for doubtful accounts on a quarterly basis. As of 31 July 2021 and 2020, the Company has no allowance for doubtful accounts. Revenue recognition The Company recognizes revenue from product sales when our customers obtain control of our products. This determination is based on the customer specific terms of the arrangement for wholesale operations. Upon transfer of control, the Company has no further performance obligations. All retail sales are considered COD. Due to the nature of the Company’s revenue from contracts with customers, the Company does not have material contract assets or liabilities that fall under the scope of ASC 606. The Company’s revenues accounted for under ASC 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue streams. The sales prices are generally fixed and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration. See Note 17 for revenue disaggregation table. Inventory Inventory consists of raw material, work in progress (live plants and plants in the drying process), finished goods, and consumables. The Company values its raw material, finished goods and consumables at the lower of the actual costs or its current estimated market value less costs to sell. The Company values its work in progress at cost. The Company periodically reviews its inventory for obsolete and potentially impaired items. As of 31 July 2021 and 2020, the Company has no allowance for inventory obsolescence. Loans receivable The Company carries its loans receivable at cost and are reviewed for indicators of impairment at least annually. Property and equipment Property and equipment are recorded at cost and are amortized over their estimated useful lives on a straight-line basis as follows: Office equipment 7 years Cultivation equipment 7 years Production equipment 7 years Kitchen equipment 7 years Vehicles 7 years Vault equipment 7 years Leasehold improvements shorter of useful life or the term of the lease Intangible Assets Intangible assets acquired from third parties are measured initially at fair value and either classified as indefinite life or finite life depending on their characteristics. Intangible assets with indefinite lives are tested for impairment at least annually and intangible assets with finite lives are reviewed for indicators of impairment at least annually. The Company’s brands and licenses acquired from NMG have indefinite lives; therefore no amortization is recognized. The Company’s brands and licenses acquired by NMG SD have a finite life of 10 years, brands and licenses acquired by NMG LB and NMG OH 1 have a finite life of 10 years, customer relationships acquired by NMG OH 1 have a finite life of five years and are amortized over these estimated useful lives on a straight-line basis. Goodwill Goodwill represents the excess of the aggregate purchase price paid over the fair value of the net assets acquired in our business combinations. Goodwill is not amortized and is tested for impairment at least annually or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Events or changes in circumstances that could trigger an impairment review include a significant adverse change in business climate, an adverse action or assessment by a regulator, unanticipated competition, a loss of key personnel, significant changes in the manner of our use of the acquired assets or the strategy for our overall business, significant negative industry or economic trends, or significant underperformance relative to expected historical or projected future results of operations. The Company has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying value, including goodwill. If, after assessing the totality of events or circumstances, the Company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, additional impairment testing is not required. The Company tests for goodwill impairment annually during its fourth quarter. Income taxes Deferred income taxes are reported for timing differences between items of income or expense reported in the consolidated financial statements and those reported for income tax purposes in accordance with ASC 740, “Income Taxes”, which requires the use of the asset/liability method of accounting for income taxes. Deferred income taxes and tax benefits are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases, and for tax losses and credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company provides for deferred taxes for the estimated future tax effects attributable to temporary differences and carry-forwards when realization is more likely than not. Equity Method Investments The Company utilizes the equity method when accounting for investments in which the Company is able to exercise significant influence, but does not hold controlling interest. Significant influence is generally presumed to exist when the Company owns between 20% to 50% of the investee. Under the equity method of accounting, the investee's financials are not consolidated within the Company's financial statements. Basic and diluted net loss per share The Company computes net income (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive. Potentially dilutive options of 9,855,000 and warrants of 17,215,284 existed at 31 July 2021. This figure does not include 3,200,000 warrants issued to the Agent pursuant to the Loan Agreement, which warrants are held in escrow by us and are to be released to the Agent if we draw on the Delayed Draw Term Loan by December 31, 2021, or cancelled if we do not draw on the Delayed Draw Term Loan. Each warrant, if released to the Agent, will entitle the holder to acquire one share of common stock at an exercise price of US$0.45 per share until July 19, 2025. Comprehensive loss ASC 220, “Comprehensive Income”, establishes standards for the reporting and display of comprehensive income/loss and its components in the consolidated financial statements. As of 31 July 2021 and 2020, the Company reported foreign currency translation adjustments as other comprehensive income or loss and included a schedule of comprehensive income/loss in the consolidated financial statements. Foreign currency translation The Company’s functional currency is the Canadian dollar and its reporting currency is in U.S. dollars. The Company’s subsidiaries have a functional currency in U.S. dollars. The consolidated financial statements of the Company are translated to U.S. dollars in accordance with ASC 830, “Foreign Currency Matters”. Exchange gains and losses on inter-company balances that form part of the net investment in foreign operations are included in other comprehensive income. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. The exchange rates used to translate Canadian dollar to U.S. dollar was 0.8024 for monetary assets and liabilities and 0.7855 as an average rate for transactions occurred during the year ended 31 July 2021. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the determination of net loss. Stock-based compensation The Company estimates the fair value of each stock option award at the grant date by using the Black-Scholes Option Pricing Model. The fair value determined represents the cost for the award and is recognized over the required service period, generally defined as the vesting period. The Company’s accounting policy is to recognize forfeitures as they occur. Fair value measurements The Company accounts for certain assets and liabilities at fair value. The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. We categorize each of our fair value measurements in one of these three levels based on the lowest level input that is significant to the fair value measurement in its entirety. These levels are: · Level 1 – inputs are based upon unadjusted quoted prices for identical instruments in active markets. · Level 2 – inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques (e.g. the Black-Scholes model) for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based observable inputs including interest rate curves, credit spreads, foreign exchange rates, and forward and spot prices for currencies. · Level 3 – inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models. Our Level 3 assets and liabilities include investments in other private entities, and goodwill and intangible assets, when they are recorded at fair value due to an impairment charge. Unobservable inputs used in the models are significant to the fair values of the assets and liabilities. The Company measures equity investments without readily determinable fair values on a nonrecurring basis. The fair values of these investments are determined based on valuation techniques using the best information available, and may include quoted market prices, market comparables, and discounted cash flow projections. The Company’s convertible note receivable was measured at fair value (Note 6). Other current financial assets and current financial liabilities have fair values that approximate their carrying values. Use of estimates and assumptions The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenditures during the reporting period. Actual results could differ from these estimates. Lease accounting The Company adopted ASC 842, leases effective 1 August 2019 using a modified retrospective approach. Under ASC 842, leases are separated into two classifications: operating leases and financial leases. Lease classification under ASC 842 is relatively similar to ASC 840. For a lease to be classified as a finance lease, it must meet one of the five finance lease criteria: (1) transference of title/ownership to the lessee, (2) purchase option, (3) lease term for major part of the remaining economic life of the asset, (4) present value represents substantially all of the fair value of the asset, and (5) asset specialization. Any lease that does not meet these criteria is classified as an operating lease. ASC 842 requires all leases to be recognized on the Company’s balance sheet. Specifically, for operating leases, the Company recognize a right-of-use asset and a corresponding lease liability upon lease commitment.

Financial Instruments

Financial Instruments	12 Months Ended
	Jul. 31, 2021
Financial Instruments
4. Financial Instruments	4. Financial Instruments The following table represents the Company’s assets that are measured at fair value as of 31 July 2021 and 2020: As of 31 July 2021 As of 31 July 2020 Financial assets at fair value Cash $ 7,374,194 $ 1,352,130 Convertible loan receivable 1,648,816 1,290,263 Total financial assets at fair value $ 9,023,010 $ 2,642,393 Management of financial risks The financial risk arising from the Company’s operations include credit risk, liquidity risk, interest rate risk and currency risk. These risks arise from the normal course of operations and all transactions undertaken are to support the Company’s ability to continue as a going concern. The risks associated with these financial instruments and the policies on how to mitigate these risks are set out below. Management manages and monitors these exposures to ensure appropriate measures are implemented on a timely and effective manner. Credit risk Credit risk is the risk that one party to a financial instrument will fail to discharge an obligation and cause the other party to incur a financial loss. The Company is not exposed to credit risk related to cash and cash equivalents as it does not hold cash in excess of federally insured limits, with major financial institutions. Credit risk associated with the convertible loans receivable (including the investment in and advances to Green Light District Holdings, Inc.) arises from the possibility that the principal and/or interest due may become uncollectible. The Company mitigates this risk by managing and monitoring the underlying business relationship. Liquidity risk Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company ensures, as far as reasonably possible, that it will have sufficient capital in order to meet short-term business requirements, after taking into account cash flows from operations and the Company’s holdings of cash. The Company has cash flows from operations of $294,965 for the year ended 31 July 2021, and had working capital of $7,852,848 at 31 July 2021. The Company outlined substantial doubt about its ability to continue as a going concern in a prior quarter which has been alleviated by securing long term debt, cash flow positive operations and increased sales. The Company anticipates that current cashflow positive operations, cash on hand and working capital will ensure coverage for all expenses associated with current operations for at least the next 15 months from the issuance of these financial statements. Management believes that the Company has access to capital resources through potential public or private issuances of debt or equity securities to further contribute to the growth of the company. Interest rate risk Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is not exposed to interest rate risk as it does not hold financial instruments that will fluctuate in value due to changes in interest rates. Currency risk Currency risk is the risk that the fair values of future cash flows of a financial instrument will fluctuate because they are denominated in currencies that differ from the respective functional currency. The Company is exposed to currency risk by incurring expenditures and holding assets denominated in currencies other than its functional currency.

Inventory

Inventory	12 Months Ended
	Jul. 31, 2021
Inventory
5. Inventory	5. Inventory 31 July 2021 31 July 2020 Work in progress $ 503,215 $ 211,621 Finished goods 1,547,493 959,939 Consumables 885,448 598,277 Total $ 2,936,156 $ 1,769,837

Convertible loan receivable

Convertible loan receivable	12 Months Ended
	Jul. 31, 2021
Convertible loan receivable
6. Convertible loan receivable	6. Convertible loan receivable Effective March 15, 2019, the Company, through its wholly owned subsidiaries, DEP Nevada and NMG, entered into a convertible loan agreement and a management agreement with Comprehensive Care Group LLC (“CCG”), an Arkansas limited liability company, with respect to the development of a medical cannabis dispensary facility in West Memphis, Arkansas. The convertible loan agreement can be extended by either party and the current agreement has a maturity date of March 30, 2022. Under no circumstances the maturity date of the convertible loan agreement shall extend beyond the expiration of the management agreement as described below. Pursuant to the management agreement, NMG will provide operations and management services, including management, staffing, operations, administration, oversight, and other related services. Under the management agreement, NMG will be required to obtain approval from CCG for any key decisions as defined in the agreement and accordingly the Company does not control CCG. NMG will be paid a monthly management fee equal to 66.67% of the monthly net profits of CCG, subject to conversion of the convertible loan as discussed below upon which the monthly management fee shall be $6,000 per month, unless otherwise agreed by the parties in writing. The management agreement has an expiration of March 15, 2024 and can be mutually extendable. The convertible loan agreement is for an amount up to $1,250,000 from DEP to CCG with proceeds to be used to fund construction of a facility, working capital and initial operating expenses. The loan bears interest at a fixed rate of $6,000 per month until the parties mutually agree to increase the interest. Upon the latter of one year of granting of a medical cannabis dispensary license by the appropriate authorities or one year after entering into the convertible loan agreement, DEP may elect to convert the loan into preferred units of CCG equal to 40% of all outstanding units of CCG, subject to approval of the Arkansas Medical Marijuana Commission. The Company evaluated the convertible loan receivable’s settlement provisions and elected the fair value option in accordance with ASC 825 “Financial Instruments”, to value this instrument. Under such election, the loan receivable is measured initially and subsequently at fair value, with any changes in the fair value of the instrument being recorded in the consolidated financial statements as a change in fair value of the financial instruments. The Company estimates the fair value of this instrument by first estimating the fair value of the straight debt portion, excluding the embedded conversion option, using a discounted cash flow model. The Company then estimates the fair value of the embedded conversion option using the Black-Scholes Option Pricing Model. The sum of these two valuations is the fair value of the loan receivable balance of $1,648,816. Management believes that the accretion of the straight debt portion and embedded derivative related to the conversion option are not material due to the short term maturity of the loan. At 31 July 2021, the Company had advanced $1,648,816 (2020 - $1,290,263) and accrued interest income of $72,000 (2020 - $90,000) for the year ended 31 July 2021. As of 31 July 2021, total interest receivable was $150,000 (2020 - $78,000).

Loan receivable

Loan receivable	12 Months Ended
	Jul. 31, 2021
Convertible loan receivable
7. Loan receivable	7. Loan receivable The loan receivable at 31 July 2021 in the amount of $239,834 acquired from NMG LB (Note 11) is due from an arm’s length party that is unsecured, non-interest bearing and due on demand.

Investment in NMG Ohio LLC

Investment in NMG Ohio LLC	12 Months Ended
	Jul. 31, 2021
Investment in NMG Ohio LLC
8. Investment in NMG Ohio LLC	8. Investment in NMG Ohio LLC On 7 June 2018, the Company acquired a 30% interest in NMG Ohio, which had a cannabis dispensary and a provisional production license. On 31 January 2019, the Company entered into a definitive agreement (“Definitive Agreement”) to acquire 100% ownership of NMG Ohio, or the remaining 70% interest for total cash payments of $1,575,000 and issuance of 3,173,864 common shares of the Company. As of 31 July 2019, the Company had issued 2,380,398 of the 3,173,864 common shares with a fair value of $1,448,805. During the year ended 31 July 2019, the Company made cash payments of $1,181,250. The remaining cash payments totaling $393,750 were paid in October 2020 and the remaining issuance of 793,466 common shares were issued in October 2020. The dispensary license and the assets and liabilities associated with The Clubhouse Dispensary were transferred into the Company’s wholly-owned subsidiary, NMG OH 1 LLC on September 4, 2020. The provisional production license remains in NMG Ohio and the Company anticipate closing the acquisition of the remaining 70% interest in NMG Ohio upon receipt of production license. Following the completion of license transfer of the Ohio dispensary on 4 September 2020 to the Company’s wholly-owned subsidiary, NMG OH 1, the Company began consolidating the assets, liabilities, revenues and expenses related to the dispensary. The Company still accounts for its 30% ownership interest in NMG Ohio as an investment using the equity method of accounting. During the period from 1 August 2020 to 4 September 2020, NMG Ohio recorded net revenues of $534,971, expenses of $490,906 and a net income of $44,065. The Company recorded an equity in earnings of $13,219 relating to its 30% pro rata share of net income which was included in other items on the statement of operations. During the period from 5 September 2020 to 31 July 2021, NMG Ohio did not have any operating activities. 31 July 2021 31 July 2020 30% equity investment: Opening balance $ 531,185 $ 134,066 Equity-method investment change from earnings 13,219 397,119 Total equity investment in NMG Ohio 544,404 531,185 Acquisition of remaining 70% interest: Opening balance 2,630,055 2,630,055 Acquisition costs: Common shares issued to vendors at fair value 297,042 - Acquisition costs: Cash payments to vendors 393,750 - Foreign exchange 7,919 Total advances for remaining 70% acquisition of NMG Ohio 3,328,766 2,630,055 Impairment loss (58,382 ) Acquisition of The Clubhouse Dispensary (Note 11) (3,814,788 ) - Total investment in NMG Ohio $ - $ 3,161,240 Loan receivable (payable) to NMG Ohio Opening balance $ (466,495 ) $ 701,781 Advances provided to NMG Ohio 1,120,015 112,869 Advances received from NMG Ohio - (1,252,429 ) Foreign exchange 4,671 (28,716 ) Transferred to NMG OH 1 and eliminated on consolidation 233,088 - Loan receivable (payable) to NMG Ohio $ 891,279 $ (466,495 ) During the year ended 31 July 2021, the Company provided $891,279 to NMG Ohio related to build-out of production facility and license fees.

Investment in and advances to G

Investment in and advances to GLDH	12 Months Ended
	Jul. 31, 2021
Investment in NMG Ohio LLC
9. Investment in and advances to GLDH	9. Investment in and advances to GLDH Interim Agreement – 28 November 2018 On 28 November 2018, the Company entered into a binding interim agreement (the “Interim Agreement”) with GLDH, a private company incorporated under the laws of Delaware, and David Barakett (“Barakett”) whereby the Company agreed to acquire 100% of the issued and outstanding common shares of GLDH in connection with the issuance of convertible notes (the “Transaction”). GLDH held a number of assets relating to the production and sale of cannabis products in the United States of America. The Transaction was contingent upon the Company completing its due diligence. The terms of the Interim Agreement include the following: The Company was to issue to Barakett common shares of the Company (the “Earn Out Shares”) based on the CSE listed 5-day VWAP of the common shares of the Company and at the USD/CAD exchange rate at the close of market on 27 November 2018. The common shares of the Company had a 5-day VWAP of CAD$0.7439 at a USD/CAD exchange rate of 1.3296 and as a result the Company agreed to issue up to a maximum of 11,255,899 common shares with a maximum consideration of US$6,297,580 or CAD$8,373,263. Barakett was eligible to receive Earn Out Shares for a period of 12 months on the following basis: 1. upon GLDH obtaining all of (i) the Long Beach Recreational License; (ii) the San Diego Medical License; (iii) the San Diego Recreational License; and (iv) the San Diego State License (“Milestone I”), the issuance of Earn Out Shares to Barakett totaling 5,627,950 shares (50% of the total Earn Out Shares); 2. upon GLDH achieving total attributable revenues of at least US$3,300,000 over a period of three consecutive months from each of the Long Beach dispensary, the San Diego dispensary and Las Vegas ShowGrow (“Milestone II”), the issuance of Earn Out Shares to Barakett totaling 4,502,360 (40% of the total Earn Out Shares); and 3. prior to the completion of Milestone I and Milestone II, and upon completion of a certain audit of GLDH showing no taxes outstanding or any unknown material liabilities for GLDH, the issuance of Earn Out Shares to Barakett totaling 1,125,589 shares (10% of the total Earn Out Shares). Additionally, the Company made an investment into GLDH by way of a US$5,200,000 senior secured convertible note (the “Note”) bearing interest at a rate of 20% per annum to be repaid to the Company on 28 November 2020 unless converted by the Company in accordance with the agreement. The Note was secured by a general security agreement and a UCC-1 financing statement in all U.S. states where GLDH has assets. Barakett provided a personal guarantee to the Company for the Note. In order for the Company to fund the Note: 1. the Company entered into a loan agreement with Australis Capital Inc. (“Australis”). see also Note 20 whereby Australis provided the Company a two-year US$4,000,000 loan; and 2. Australis exercised 3,206,160 warrants at a price of CAD$0.50 per common share for aggregate proceeds of approximately US$1,200,000 converted using an exchange rate of 0.7518. Definitive Agreement (Superseding Interim Agreement) On 3 July 2019, the Company entered into the following agreements with GLDH and other third parties: 1. a definitive asset purchase agreement (the “Purchase Agreement”) between the Company’s wholly owned subsidiary, NMG Long Beach, LLC (“NMG LB”), GLDH and Airport Collective, Inc. to acquire 100% ownership interest in GLDH’s Long Beach, California dispensary; 2. a settlement agreement (“NMG SD Settlement Agreement”) between the Company and its subsidiaries, and GLDH and its subsidiaries, to acquire a 60% ownership interest in GLDH’s San Diego, California dispensary; and 3. a lease assignment (the “Lease Assignment Agreement”) on the San Diego operation between the Company’s 60%-owned subsidiary, NMG San Diego, LLC (“NMG SD”), Green Road, LLC, Show Grow San Diego, LLC (“SGSD”), and SJJR LLC. The Purchase Agreement, NMG SD Settlement Agreement and Lease Assignment agreement supersede the Interim Agreement and are subject to certain closing conditions including receipt of applicable licences. 1. The Purchase Agreement was executed under the following terms: The purchase price is USD$6,700,000 (the “Purchase Price”). The consideration under the Purchase Agreement includes the following on closing: i. The USD$5,200,000 Note and accrued interest is to be applied towards the Purchase Price; and ii. USD$1,500,000 to be paid in common shares of the Company at a price of CAD$0.7439 per common share to a maximum of 2,681,006 common shares (the “Share Payment”) (issued) (Note 16) upon NMG LB receiving the transfer of all licenses, permits and BCC authorizations for NMG LB to conduct medical and adult-use commercial cannabis retail operations. The Share Payment is subject to reduction equal to the net liability of GLDH and Airport Collective. 2. The NMG SD Settlement Agreement’s consideration includes the following on closing: i. USD$500,000 to be paid in common shares (624,380 common shares issued) (Note 16) to SGSD at a share price equal to the maximum allowable discount pursuant to Canadian Securities Exchange policies, upon execution of the settlement agreement; ii. USD$750,000 to be paid in common shares (issued) (Note 16) to Barakett at a price of CAD$0.7439 per 4common share to a maximum of 1,340,502 Common Shares (the “DB Share Payment”) upon NMG SD receiving all licenses, permits and authorizations for NMG SD to conduct medical commercial cannabis retail operations; and iii. USD$750,000 to be paid in common shares (issued) (Note 16) to Barakett at a price of CAD$0.7439 per common share to a maximum of 1,340,502 common shares (the “DB Additional Shares Payment”) upon NMG SD receiving all licenses, permits and authorizations for NMG SD to conduct adult-use commercial cannabis retail operations. 3. The Lease Assignment Agreement was executed under the following terms: The Company is required to issue cash and share payments to the landlord as follows: i. USD$700,000, payable in common shares (1,031,725 common shares issued) (Note 16) at a share price equal to the maximum allowable discount pursuant to Canadian Securities Exchange policies, upon execution of the assignment agreement; ii. USD$783,765, payable in cash (paid), within 5 business days following execution of the assignment agreement (paid); and iii. USD$750,000, payable in cash (paid), including interest at 5% per annum, upon receipt of the San Diego Conditional Use Permit allowing adult-use commercial cannabis retail operations. Additionally: 1. The Company is to provide a loan to GLDH in the amount of USD$200,000 at an interest rate of 12% per annum, accrued and compounded quarterly and due within 3 years (provided); 2. The Company is to enter into a consulting agreement with Barakett through NMG LB to provide certain consulting and advisory services to NMG LB, agreeing to pay Barakett a total of USD$200,000 ($50,000 paid in fiscal 2019 and additional $150,000 paid during the year ended 31 July 2020); 3. The Company will forgive approximately USD$800,000 for prior operating loans advanced by the Company to GLDH; and; 4. The Company licenses certain intellectual property from Green Light District Management, LLC and GLDH (collectively referred to as “Licensor”). The Licensor grants the Company a perpetual license to utilize its operational intellectual property consisting of customer data, sales data, customer outreach strategies standard operating procedures, and other proprietary operational intellectual property. Licensor grants the Company a license for 2 years to utilize intellectual property such as trademarks and branding (the “Branding IP”). As consideration for the licenses, the Company has agreed to utilize the Branding IP until 19 June 2021 at the Company’s premises and at the San Diego retail locations for a period of 2 years from operations commencing at that location. Additionally, the Company agreed to pay the Licensor 3% of gross receipts from sales at the Long Beach dispensary. The total investment in GLDH at 31 July 2021 and 2020 is as follows: 31 July 2021 31 July 2020 Opening balance $ 8,910,854 $ 7,373,036 Share issuances - 4,092,175 Share payment reduction - (793,416 ) Interest income accrued on the Note 88,143 1,040,000 Advances for working capital 3,030 2,143,609 Lease Assignment Agreement payment - 750,000 Amount transferred to Property and Equipment - (1,431,585 ) Amount transferred to Brand and Licenses - (3,585,483 ) Expensed during the year (188,879 ) (501,862 ) Foreign exchange 99,585 (175,620 ) 8,912,733 8,910,854 Impairment loss (534,165 ) - Acquisition of ShowGrow Long Beach dispensary (Note 11) (8,378,568 ) - Ending balance $ - 8,910,854 In April 2020, the Company fulfilled all obligations under the NMG SD Settlement Agreement and the Lease Assignment Agreement and completed the acquisition of a 60% owned dispensary located in San Diego (the “SD Transaction”). The SD Transaction was accounted for as an asset acquisition. The Company acquired the rights to an existing lease that was zoned for use as a cannabis dispensary. The Company owns the dispensary through a 60% owned subsidiary, NMG SD. The Company consolidated 100% of the assets, liabilities and the operations of NMG SD with 40% disclosed as a non-controlling interest.

Property and Equipment

Property and Equipment	12 Months Ended
	Jul. 31, 2021
Property and Equipment
10. Property and Equipment	10. Property and Equipment Office Equipment Cultivation Equipment Production Equipment Kitchen Equipment Vehicles Vault Equipment Leasehold Improvements Total Cost: Balance, 31 July 2020 $ 73,310 $ 478,187 $ 545,723 $ 51,108 $ 38,717 $ 2,172 $ 4,245,389 $ 5,434,606 Additions (disposals) 328,261 (12,077 ) 24,979 - - 8,163 810,410 1,159,736 Balance, 31 July 2021 401,571 466,110 570,702 51,108 38,717 10,335 5,055,799 6,594,342 Accumulated Depreciation: Balance, 31 July 2020 15,844 182,232 130,421 14,421 18,797 897 472,790 835,402 Depreciation 33,921 68,312 79,745 7,301 5,531 893 669,447 865,150 Balance, 31 July 2021 49,765 250,544 210,166 21,722 24,328 1,790 1,142,237 1,700,552 Net Book Value: At 31 July 2020 57,466 295,955 415,302 36,687 19,920 1,275 3,772,599 4,599,204 At 31 July 2021 $ 351,806 $ 215,566 $ 360,536 $ 29,386 $ 14,389 $ 8,545 $ 3,913,562 $ 4,893,790 For the year ended 31 July 2021, a total depreciation of $765,857 (2020 - $112,025) was included in General and Administrative Expenses and a total depreciation of $453,884 (2020 - $266,080) was included in Cost of Sales.

Business Acquisition

Business Acquisition	12 Months Ended
	Jul. 31, 2021
Business Acquisition
11. Business Acquisition	11. Business Acquisition The Clubhouse dispensary The acquisition of The Clubhouse dispensary allows the Company to expand into the State of Ohio. On 4 September 2020, NMG OH 1 received all approvals and final license and name transfer from the Ohio Department of Pharmacy for Clubhouse dispensary located in Elyria, Ohio. The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations. The following table summarizes the fair value of the assets acquired and the liabilities assumed, which were recorded as of the acquisition date, as well as the aggregate consideration for the acquisition of NMG OH 1 made by the Company: Purchase consideration $ 3,814,788 Assets acquired: Cash 257,462 Amounts receivable 510,367 Prepaid expenses 4,965 Inventory 178,898 Property and equipment 763,951 Licenses and customer relationships 2,710,000 Liabilities assumed: Trade payable and accrued liabilities (443,589 ) Net assets acquired 3,982,054 Bargain purchase (167,266 ) TOTAL $ 3,814,788 ShowGrow Long Beach dispensary The acquisition of ShowGrow Long Beach dispensary allows the Company to expand its presence in the California market. On 28 August 2020, NMG LB received all approvals and final license transfer for the ShowGrow Long Beach dispensary. The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations. The following table summarizes the fair value of the assets acquired and the liabilities assumed, which were recorded as of the acquisition date, as well as the aggregate consideration for the acquisition of NMG LB made by the Company: Purchase consideration $ 8,378,568 Assets acquired: Cash 65,340 Prepaid expenses 15,264 Inventory 177,930 Property and equipment 5,402 Loan receivable (Note 7) 239,834 Liabilities assumed: Trade payable and accrued liabilities (732,262 ) Income taxes payable (423,931 ) Loans payable (Note 14) (12,190 ) Net liabilities acquired (664,613 ) Brand and licenses 6,510,000 Goodwill 2,533,181 TOTAL $ 8,378,568 Pro Forma The following table summarizes the results of operations of both The Clubhouse Dispensary and NMG LB since the acquisition dates included in the Company’s consolidated results of operations for the year ended 31 July 2021: The Clubhouse Dispensary NMG LB Revenue $ 6,643,561 $ 5,940,087 Net income $ 1,565,316 $ 283,569 The following table summarizes our consolidated results of operations for the years ended 31 July 2021 and 2020 as though the acquisitions of The Clubhouse Dispensary and NMG LB had occurred on 1 August 2019. Year ended 31 July 2021 As Reported Pro Forma (unaudited) Revenue 26,900,869 27,972,106 Net loss (1,976,461 ) (1,913,199 ) Year ended 31 July 2020 As Reported Pro Forma (unaudited) Revenue 6,232,521 16,859,485 Net income (4,598,389 ) (4,238,491 ) The unaudited pro forma information set forth above is for informational purposes only and include all adjustments necessary for the fair presentation, in all material respects, of the Company’s combined operations including The Clubhouse Dispensary and NMG LB as if the business combinations occurred on 1 August 2019. No adjustments have been made to reflect potential cost savings that may occur subsequent to completion of the transactions. The unaudited pro forma financial information is not intended to reflect the results of operations of the Company which would have actually resulted had the proposed transaction been effected on the date indicated above. Further, the unaudited pro forma financial information is not necessarily indicative of the results of operations that may be obtained in the future. The actual pro forma adjustments will depend on a number of factors, and could result in a change to the unaudited pro forma financial information.

Goodwill and Intangible Assets

Goodwill and Intangible Assets Net	12 Months Ended
	Jul. 31, 2021
Goodwill and Intangible Assets Net
12. Goodwill and Intangible Assets Net	12. Goodwill and Intangible Assets, Net The following table displays the changes in the gross carrying amount of goodwill: Balance at July 31, 2020 $ 2,635,721 Increase due to acquisitions 2,533,181 Balance at July 31, 2021 $ 5,168,902 There were no impairments recorded against goodwill during the year ended July 31, 2021 and 2020, respectively. Intangible assets consisted of the following: As of 31 July 2021 Gross carrying amount Weighted average life (years) Accumulated amortization Net carrying amount Intangible assets: Brand $ 247,000 - $ - $ 247,000 Licenses 20,718,508 10.0 (1,184,175 ) 19,534,333 Customer relationships 90,000 5.0 (16,265 ) 73,735 Total intangible assets $ 21,055,508 $ (1,200,440 ) $ 19,855,068 As of 31 July 2020 Gross carrying amount Weighted average life (years) Accumulated amortization Net carrying amount Intangible assets: Brand $ 247,000 - $ - $ 247,000 Licenses 11,588,508 10.0 (78,025 ) 11,510,483 Total intangible assets $ 11,835,508 $ (78,025 ) $ 11,757,483 Amortization expense for intangible assets was $1,122,145 and $78,025 for the years ended 31 July 2021 and 2020, respectively. Included in the licenses is $7,925,000 of indefinite lived assets. The expected amortization of the intangible assets, as of 31 July 2021, for each of the next five years and thereafter is as follows: 2022 $ 1,199,162 2023 1,199,162 2024 1,199,162 2025 1,199,162 2026 1,199,162 Thereafter 5,687,258 $ 11,683,068

Related Party Balances and Tran

Related Party Balances and Transactions	12 Months Ended
	Jul. 31, 2021
Related Party Balances and Transactions
13. Related Party Balances and Transactions	13. Related Party Balances and Transactions In addition to those disclosed elsewhere in these consolidated financial statements, related party transactions paid/accrued for the years ended 31 July 2021 and 2020 are as follows: For the year ended 31 July 2021 For the year ended 31 July 2020 A company controlled by the President, Chief Executive Officer and a director Management fees $ 159,657 $ 154,439 A company controlled by the Chief Financial Officer and a director Management fees 109,487 91,594 A company controlled by a former director and former President of NMG Management fees 65,000 141,665 A company controlled by the Corporate Secretary Management fees 70,990 63,853 Consulting fees - 3,044 A company controlled by the former Chief Executive Officer and a former director Management fees - 9,224 $ 405,134 $ 463,819 Amounts owing to related parties at 31 July 2021 and 2020 are as follows: a) As of 31 July 2021, the Company owed $26,841 (2020 - $14,229) to the Chief Executive Officer of the Company and a company controlled by him. b) As of 31 July 2021, the Company owed $18,914 (2020 - $7,833) to the Chief Financial Officer of the Company and a company controlled by him. c) As of 31 July 2021, the Company owed $6,319 (2020 - $5,875) to the Corporate Secretary of the Company and a company controlled by him. d) As of 31 July 2021, the Company owed $Nil (2020 - $25,000) to the former director and former President of NMG of the Company and a company controlled by him. The above amounts owing to related parties are unsecured, non-interest bearing and are due on demand.

Loan Payable

Loan Payable	12 Months Ended
	Jul. 31, 2021
Loan Payable
14. Loan Payable	14. Loans payable The loan payable at 31 July 2021 in the amount of $16,874 assumed from NMG LB (Note 11) is unsecured, non-interest bearing and has no set terms of repayment. On 19 July 2021, the Company entered into and closed a loan agreement (the “Loan Agreement”) with FG Agency Lending LLC (the “Agent”) and Bomind Holdings LLC (the “Lender”). Upon entering into the Loan Agreement, the Lender provided the initial term loan (the “Initial Term Loan”) in the face amount of $6,666,667 of which $6,000,000 was advanced to the Company with the 10% representing an origination discount as consideration for the use or forbearance of money. The Company may draw upon the remaining face amount of $4,444,444 (the “Delayed Draw Term Loan”) upon providing a 30-day request to the Agent by 1 December 2021, whereby $4,000,000 will be advanced to the Company after applying the 10% origination discount. The Initial Term Loan and the Delayed Draw Term Loan mature on 19 July 2025 and bear interest at a rate of 13% per annum payable on the first day of each month hereafter. Pursuant to the Loan Agreement, the Company issued an aggregate of 8,000,000 common stock purchase warrants (each, a “Warrant”) to the Agent of which (i) 4,800,000 Warrants will entitle the holder to acquire shares of common stock (each, a “Warrant Share”) at an exercise price of $0.40 per Warrant Share until July 19, 2025, and (ii) 3,200,000 Warrants will be held in escrow by us and released to the Agent at the time the Company draws on the Delayed Draw Term Loan, or cancelled if we do not draw on the Delayed Draw Term Loan, which will entitle the holder to acquire a Warrant Share at an exercise price of $0.45 per Warrant Share until July 19, 2025. The 4,800,000 Warrants were valued at $1,037,146 using the Black Scholes Option Pricing Model using the following assumptions: Expected life of the options 4.00 years Expected volatility 139 % Expected dividend yield 0 % Risk-free interest rate 0.55 % The Company also paid agent fee, legal fees and other fees in the amount of $175,758. The Initial Term Loan is secured by certain of the Company’s assets, equity interest in subsidiaries and various agreements, under the Security Agreement, the Pledge Agreement and the Omnibus Collateral Assignment.

Operating leases

Operating leases	12 Months Ended
	Jul. 31, 2021
Operating leases
15. Operating leases	15. Operating leases a) On 10 November 2017, NMG entered into a revised five-year lease agreement for the property located at 3375 Pepper Lane, Las Vegas, NV, containing approximately 18,000 square feet. The Company has four options to extend the lease and each option is for five years. The monthly rent was $12,500 plus common area expenses, which increased to $12,875 plus common area expenses on 1 January 2019 and again increased to $13,261 plus common are expenses on 1 December 2019. The guaranteed minimum monthly rent is subject to a 2% increase on each anniversary date of the lease. b) On 9 April 2019, NMG entered into a three-year lease agreement for the property located at 6420 Sunset Corporate Drive, Las Vegas, NV, containing approximately 7,700 square feet. The Company has one option to extend the lease for an additional three-year term and an option to purchase the property at any point during the initial term. The monthly rent is $6,026 plus $1,129 in common area expenses, totaling $7,156 every month. c) On 24 April 2020, the Company assumed a five-year lease dated 1 December 2018, as amended on 13 June 2019, for the property located at 7625 Carroll Road, San Diego, CA. The Company has three options to extend the lease and each option is for five years. The monthly rent is $15,450 per month increasing by 3% every year until 1 December 2022.The lease contains a sale bonus provision of $1,000,000 or 10% of the purchase price of the entire business, whichever is greater, in the event of sale or assignment of the lease. d) On August 2, 2018, NMG Ohio, LLC entered into a three-year lease agreement for the property located at 709 Sugar Lane, Elyria, Ohio 44035, containing approximately 4,100 square feet. The Company has three options to extend the lease and each option is for three years. The rent is $4,000 per month increasing by 5% starting on 1 July 2021 and 1 July 2024. e) On 28 August 2020, the Company assumed a five-year lease dated 10 January 2017, as amended on 7 September 2018, for the property located at 3411 E. Anaheim St., Long Beach, California. The Company has one option to extend the lease for five years. The rent is $7,317 per month increasing by 3% every year until 10 January 2022. f) The Company also has various lease agreements in Michigan (Note 19). The Company has not yet taken possession of the premises. On adoption of ASC 842, Lease Accounting, the Company recognized right-of-use assets (Notes 10 and 18), and a corresponding increase in lease liabilities, in the amount of $1,181,143 which represented the present value of future lease payments using a discount rate of 12% per annum related to the two leases in Nevada, USA. The Company adopted the modified retrospective approach on adopting ASC 842 and accordingly the adoption was made effective 1 August 2019, with no restatement of the prior year comparatives. On the assumption of the lease in San Diego, California, the Company recognized right-of-use assets (Notes 10 and 18), and a corresponding increase in lease liabilities, in the amount of $662,800 which represented the present value of future lease payments using a discount rate of 12% per annum. During the year ended 31 July 2021, the Company recorded a total lease expense of $577,272 related to the accretion of lease liabilities and the depreciation of right-of-use assets of which $431,427 was included in General and Administrative Expenses and $145,845 was included in Cost of Sales. Supplemental cash flow information related to leases was as follows: Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 536,985 Right-of-use assets obtaining in exchange for lease obligations: Operating leases $ 380,832 Weighted-average remaining lease term – operating leases 6.27 years Weighted-average discount rate – operating leases 12 % The discount rate of 12% was determined by the Company as the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. Maturities of lease liabilities were as follows: Year Ending 31 July Operating Leases 2022 (1) $ 1,051,964 2023 596,273 2024 607,262 2025 617,942 2026 and thereafter 1,366,633 Total lease payments $ 4,240,074 Less imputed interest (1,155,134 ) Total $ 3,084,940 Less current portion (761,415 ) Long term portion 2,323,525

Capital Stock

Capital Stock	12 Months Ended
	Jul. 31, 2021
Capital Stock
16. Capital Stock	16. Capital Stock The Company’s authorized share capital comprises 900,000,000 Common Shares, with a $0.0001 par value per share. On 12 August 2019, the Company issued a total of 4,337,111 common shares of the Company in connection with the Purchase Agreement, NMG SD Settlement Agreement and the Lease Assignment Agreement valued at $2,752,782 (Notes 9 and 18). On 12 August 2019, the Company issued 81,591 common shares upon exercise of 81,591 warrants at a price of CAD$0.66 per common share for aggregate proceeds of $40,688 (CAD$53,850). On 12 September 2019, the Company issued 38,912 common shares upon exercise of 38,912 warrants at a price of CAD$0.66 per common share for aggregate proceeds of $19,405 (CAD$25,682). On 4 October 2019, the Company issued 22,727 common shares upon exercise of 22,727 warrants at a price of CAD$0.90 per common share for aggregate proceeds of $15,455 (CAD$20,454). On 4 November 2019, the Company issued 22,485 common shares upon exercise of 22,485 warrants at a price of CAD$0.90 per common share for aggregate proceeds of $15,291 (CAD$20,236). On 14 November 2019, the Company issued 70,500 previous escrowed shares with a fair value of $17,786 to Toro Pacific Management Inc. in connection with the acquisition of NMG (Note 18). On 24 April 2020, the Company issued 2,681,004 common shares valued at $1,342,175 (CAD$1,796,272) in relation to NMG SD Settlement Agreement (Notes 9 and 18). On 14 May 2020, the Company issued 70,500 previous escrowed shares with a fair value of $15,760 to Toro Pacific Management Inc. in connection with the acquisition of NMG. On 1 July 2020, the Company issued 2,909,091 shares of common stock valued at $1,197,084 to Australis pursuant to the conversion of the convertible debenture (Note 10). On 21 October 2020, the Company issued 793,466 common shares valued at $297,042 in relation to acquiring the remaining 70% interest in NMG Ohio (Notes 8 and 11). On 14 November 2020, the Company issued 70,500 previously escrowed shares with a fair value of $19,703 to Toro Pacific Management Inc. in connection with the acquisition of NMG. During the year ended July 31, 2021, the Company issued 700,000 common shares upon exercise of 700,000 stock option awards with an exercise price of CAD$0.57 per common share for proceeds of $317,045 (CAD$399,000). The Company has 2,681,006 common shares held in escrow, in which a portion are subject to not be released, but eventually returned and cancelled attributed to its acquisition of the ShowGrow Long Beach dispensary (Notes 9 and 11). Stock options The Company previously approved an incentive stock option plan, pursuant to which the Company may grant stock options up to an aggregate of 10% of the issued and outstanding common shares in the capital of the Company from time to time. Number of options Weighted average exercise price Weighted average contractual term remaining (in years) Aggregate intrinsic value Outstanding at 31 July 2019 6,075,000 CAD$ 0.62 3.69 CAD$ 1,675,750 Granted 5,505,000 CAD$ 0.80 Cancelled (2,425,000 ) CAD$ 0.73 Outstanding at 31 July 2020 9,155,000 CAD$ 0.70 3.48 CAD$ - Granted 1,500,000 CAD$ 0.61 Cancelled (100,000 ) CAD$ 0.66 Exercised (700,000 ) CAD$ 0.57 Outstanding at 31 July 2021 9,855,000 CAD$ 0.71 2.76 CAD$ 3,750 Vested and fully exercisable at 31 July 2021 7,055,000 CAD$ 0.70 2.30 CAD$ 2,812 On 21 August 2019, the Company issued 2,850,000 stock options with an exercise price of CAD$0.88 per share for a term of five years expiring on 21 August 2024. The options are subject to vesting provisions such that 25% of the options vest six months from the date of grant, 25% of the options vest twelve months from the date of grant, 25% of the options vest eighteen months from the date of grant and 25% of the options vest twenty-four months from the date of grant. During the year ended 31 July 2020, the Company cancelled 950,000 stock options in this series due to forfeiture. The total fair value of the stock options granted was calculated to be $1,373,856 (CAD$1,818,232) using the Black-Scholes Option Pricing Model with the following assumptions: Expected life of the options 3.125 years Expected volatility 195 % Expected dividend yield 0 % Risk-free interest rate 1.28 % During the year ended 31 July 2021, the Company recorded a stock-based compensation of $314,758 (CAD$405,450) (2020 - $977,571 (CAD$1,315,178)) related to these options. On 1 October 2019, the Company issued 250,000 stock options with an exercise price of CAD$0.93 per share for a term of five years expiring on 1 October 2024. The options are subject to vesting provisions such that 25% of the options vest six months from the date of grant,25% of the options vest twelve months from the date of grant, 25% of the options vest eighteen months from the date of grant and 25% of the options vest twenty-four months from the date of grant. The total fair value of the stock options granted was calculated to be $145,045 (CAD$191,960) using the Black-Scholes Option Pricing Model with the following assumptions: Expected life of the options 3.125 years Expected volatility 194 % Expected dividend yield 0 % Risk-free interest rate 1.37 % During the year ended 31 July 2021, the Company recorded a stock-based compensation of $42,840 (CAD$55,183) (2020 - $103,570 (CAD$139,338)) related to these options. On 23 January 2020, the Company issued 200,000 stock options with an exercise price of CAD$0.88 per share for a term of five years expiring on 23 January 2025. The options are subject to vesting provisions such that 25% of the options vest six months from the date of grant, 25% of the options vest twelve months from the date of grant, 25% of the options vest eighteen months from the date of grant and 25% of the options vest twenty-four months from the date of grant. The total fair value of the stock options granted was calculated to be $68,645 (CAD$90,608) using the Black-Scholes Option Pricing Model with the following assumptions: Expected life of the options 3.125 years Expected volatility 173 % Expected dividend yield 0 % Risk-free interest rate 1.43 % During the year ended 31 July 2021, the Company recorded a stock-based compensation of $28,055 (CAD$36,139) (2020 - $35,470 (CAD$47,719)) related to these options. On 1 March 2020, the Company issued 250,000 stock options with an exercise price of CAD$0.41 per share for a term of five years expiring on 1 March 2025. The options are subject to vesting provisions such that 25% of the options vest six months from the date of grant, 25% of the options vest twelve months from the date of grant,25% of the options vest eighteen months from the date of grant and 25% of the options vest twenty-four months from the date of grant. The total fair value of the stock options granted was calculated to be $56,287 (CAD$75,331) using the Black-Scholes Option Pricing Model with the following assumptions: Expected life of the options 3.125 years Expected volatility 127 % Expected dividend yield 0 % Risk-free interest rate 1.11 % During the year ended 31 July 2021, the Company recorded a stock-based compensation of $28,022 (CAD$36,096) (2020 - $24,303 (CAD$32,696)) related to these options. On 30 April 2020, the Company issued 1,375,000 stock options with an exercise price of CAD$0.67 per share for a term of five years expiring on 30 April 2025. The options are subject to vesting provisions such that25% of the options vest six months from the date of grant, 25% of the options vest twelve months from the date of grant, 25% of the options vest eighteen months from the date of grant and 25% of the options vest twenty-four months from the date of grant. The total fair value of the stock options granted was calculated to be $524,432 (CAD$701,863) using the Black-Scholes Option Pricing Model with the following assumptions: Expected life of the options 3.125 years Expected volatility 133 % Expected dividend yield 0 % Risk-free interest rate 0.32 % During the year ended 31 July 2021, the Company recorded a stock-based compensation of $328,055 (CAD$422,580) (2020 - $137,368 (CAD$184,808)) related to these options. On 7 July 2020, the Company cancelled 350,000stock options with an exercise price of CAD$0.88 per share, 80,000 stock options with an exercise price of CAD$0.57 per share and 150,000 stock options with an exercise price of CAD$0.57. Subsequently, the Company issued replacement stock options of 350,000 stock options with an exercise price of CAD$0.88 per share, 80,000 stock options with an exercise price of CAD$0.57 per share and 150,000 stock options with an exercise price of CAD$0.61 under the same vesting provisions and expiry dates as the original stock options. The incremental fair value based on the difference between the replacement and original stock options immediately before they were modified was calculated to be $Nil (CAD$Nil) using the Black-Scholes Option Pricing Model with the following assumptions: Expected life of the options 2.066 years Expected volatility 116 % Expected dividend yield 0 % Risk-free interest rate 0.25 % On 6 March 2021, the Company issued 1,250,000 stock options with an exercise price of CAD$0.68 per share for a term of five years expiring on 5 March 2026. The options are subject to vesting provisions such that 25% of the options vest six months from the date of grant, 25% of the options vest twelve months from the date of grant, 25% of the options vest eighteen months from the date of grant and 25% of the options vest twenty-four months from the date of grant. The total fair value of the stock options granted was calculated to be $456,211 (CAD$577,928) using the Black-Scholes Option Pricing Model with the following assumptions: Expected life of the options 3.125 years Expected volatility 112 % Expected dividend yield 0 % Risk-free interest rate 0.49 % During the year ended 31 July 2021, the Company recorded a stock-based compensation of $194,729 (CAD$250,837) (2020 - $Nil) related to these options. On 5 April 2021, the Company issued 250,000 stock options with an exercise price of CAD$0.65 per share for a term oft three years expiring on 4 April 2024. The options are subject to vesting provisions such that25% of the options vest six months from the date of grant, 25% of the options vest twelve months from the date of grant, 25% of the options vest eighteen months from the date of grant and 25% of the options vest twenty-four months from the date of grant. The total fair value of the stock options granted was calculated to be $65,795 (CAD$82,409) using the Black-Scholes Option Pricing Model with the following assumptions: Expected life of the options 1.81 years Expected volatility 101 % Expected dividend yield 0 % Risk-free interest rate 0.51 % During the year ended 31 July 2021, the Company recorded a stock-based compensation of $39,096 (CAD$50,361) (2020 - $Nil) related to these options. Share purchase warrants and brokers’ warrants Number of warrants Weighted average exercise price Outstanding at 31 July 2019 22,514,771 CAD$1.22 Exercised (165,715 ) CAD$0.73 Expired (9,933,772 ) CAD$0.89 Outstanding at 31 July 2020 12,415,284 CAD$1.49 Issued 4,800,000 USD$0.40 Outstanding at 31 July 2021 (1) 17,215,284 CAD$1.21 (1) This figure does not include 3,200,000 warrants issued to the Agent pursuant to the Loan Agreement, which warrants are held in escrow by us and are to be released to the Agent if we draw on the Delayed Draw Term Loan by December 31, 2021, or cancelled if we do not draw on the Delayed Draw Term Loan. Each warrant, if released to the Agent, will entitle the holder to acquire one share of common stock at an exercise price of US$0.45 per share until July 19, 2025. As of 31 July 2021, the following warrants are outstanding: Number of warrants outstanding and exercisable Exercise price Expiry dates 11,780,134 CAD$ 1.50 17 May 2023 635,150 CAD$ 1.25 16 May 2023 4,800,000 USD$ 0.40 19 July 2025 17,215,284 CAD$ 1.21

Segmented Information and Major

Segmented Information and Major Customers	12 Months Ended
	Jul. 31, 2021
Segmented Information and Major Customers
17. Segmented Information and Major Customers	17. Segmented Information and Major Customers In its operation of the business, management, including our chief operating decision marker, who is also our Chief Executive Officer, reviews certain financial information, including segmented internal profit and loss statements prepared on a basis not consistent with GAAP. During the periods presented, the Company reported its financial performance based on the following segments: · Wholesale; · Retail; and · All others. Revenue and costs are generally directly attributed to our segments. However, due to the integrated structure of our business , certain costs incurred by one segment may benefit other segments. In addition, certain costs incurred at a corporate level are not allocated to our segments. Segment revenue and operating income were as follows during the years ended 31 July 2021: Year Ended July 31, 2021 Revenue Wholesale $ 8,103,674 Retail 18,797,195 All others - Total $ 26,900,869 Year Ended July 31, 2021 Operating income Wholesale $ 2,999,697 Retail 2,551,396 All others (7,527,554 ) Total $ (1,976,461 ) The Company had one operating segment for the year ended 31 July 2020. During the years ended 31 July 2021 and 2020, the Company had no major customer over 10% of its revenues.

Supplemental Disclosures with R

Supplemental Disclosures with Respect to Cash Flows	12 Months Ended
	Jul. 31, 2021
Supplemental Disclosures with Respect to Cash Flows
18. Supplemental Disclosures with Respect to Cash Flows	18. Supplemental Disclosures with Respect to Cash Flows Year Ended 31 July 2021 2020 Cash paid during the year for interest $ - $ - Cash paid during the year for income taxes $ 582,152 $ 67,717 On 12 August 2019, the Company issued a total of 4,337,111 common shares of the Company in connection with the Purchase Agreement, NMG SD Settlement Agreement and the Lease Assignment Agreement valued at $2,752,782 (Notes 9 and 16). On 30 November 2019, the Company entered into a Settlement Agreement with SD whereby the Company settled an aggregate receivable amount of $590,328 in exchange for $90,315 accounts receivable from future sale of Inventory, write-off of accounts receivable of $92,415, $25,000 future credit towards the Contribution Fee, and a production equipment valued at $235,685, resulting in a loss of $331,743. On 24 April 2020, the Company issued a total of 2,681,004 common shares of the Company in connection with the NMG SD Settlement Agreement valued at $1,342,175 (Notes 9 and 16). On 21 October 2020, the Company issued 793,466 common shares valued at $297,042 in relation to acquiring the remaining 70% interest in NMG OH 1 (Notes 8 and 16). On the assumption of the lease in Elyria, Ohio, the Company recognized right-of-use assets (Notes 8 and 10), and a corresponding increase in lease liabilities, in the amount of $234,734 which represented the present value of future lease payments using a discount rate of 12% per annum. On the assumption of the lease in Long Beach, California, the Company recognized right-of-use assets (Notes 9 and 10), and a corresponding increase in lease liabilities, in the amount of $428,066 which represented the present value of future lease payments using a discount rate of 12% per annum. On 14 November 2020, the Company issued 70,500 previously escrowed shares with a fair value of $19,703 to Toro Pacific Management Inc. in connection with the acquisition of NMG (Note 16).

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Jul. 31, 2021
Commitments and Contingencies
19. Commitments	19. Commitments and Contingencies In connection with the strategic investment agreement with Australis dated 30 October 2018 (the “Investment Agreement”) (Note 20), the Company agreed to pay a monthly service fee of $10,000 to Australis. In connection with the Company’s investment in GLDH (Note 9) and the promissory note provided by Australis, the Company agreed to increase the monthly services fee to Australis to $16,500 per month for 5 years unless ownership held by Australis drops below 10% in which the fee will cease. Following the repayment of the promissory note, the monthly service fee to Australis was reduced to $12,000 commencing June 2019. Subsequent to the year end, the Investment Agreement was terminated as well as the monthly commercial advisory and consulting fees (Note 23). On April 23, 2021, the Company’s subsidiary NMG MI 1, Inc (“NMG MI 1”) executed a lease agreement (the “Lease”) with Kendal Properties, LLC (“Kendal”) to lease finished retail space located at 885 E. Apple Ave., Muskegon, MI 49442. The term of the lease is for a period of 60 months at approximately US$5,000/month and is contingent upon NMG MI 1 receiving one or more commercial marihuana municipal licenses (the “Licenses”) from the City of Muskegon. The License(s) would allow NMG MI 1 to operate a dispensary for the distribution of adult-use and/or medical marihuana and all activities permissible under the Michigan and Muskegon Marihuana Laws. On February 10, 2020, the Company’s subsidiary NMG MI C1 Inc (“NMG MI C1”) executed a lease agreement (the”Lease”) with 254 River Street LLC(“River Street”) to lease commercial space located at 254 River Street, Manistee, MI, 49660. The term of the lease is for a period of 60 months and the lease includes rent abatement and reduced rent periods during construction and start up. Final rent is approximately US$22,500 per month and is contingent upon NMG MI C1 receiving one or more commercial marihuana municipal licenses (the “Licenses”) from the City of Manistee. The License(s) would allow NMG MI C1 to operate a cultivation facility for adultuse and/or medical marihuana and all activities permissible under the Michigan and Manistee Marihuana Laws. On February 10, 2020, the Company’s subsidiary NMG MI P1 Inc (“NMG MI P1”) executed a lease agreement (the”Lease”) with 254 River Street LLC(“River Street”) to lease commercial space located at 254 River Street, Manistee, MI, 49660. The term of the lease is for a period of 60 months and the lease includes rent abatement and reduced rent periods during construction and start up. Final rent is approximately US$7,500 per month and is contingent upon NMG MI P1 receiving one or more commercial marihuana municipal licenses (the “Licenses”) from the City of Manistee. The License(s) would allow NMG MI P1 to operate a production facility for adult-use and/or medical marihuana and all activities permissible under the Michigan and Manistee Maihuana Laws. Leases for 254 River St., Manistee, Michigan 49660 and 885 E. Apple Ave., Muskegon, Michigan 49442 were subject to the Company subsidiaries receiving approval by the State of Michigan and could be cancelled by The Company if licences were not awarded. The licenses for NMG MI P1 Inc. and NMG MI C1 Inc. were issued on July 19, 2021 and license for NMG MI 1 Inc. was issued on August 3, 2021 at which time the Company recognized these lease liabilities. Upon NMG MI 1 receiving one or more Licenses, NMG MI 1 agrees to cause the Company to issue common shares (the “Common Shares”) having a value of up to $150,000 to Kendal, with portions of the Common Shares to be issued upon the achievement of certain milestones as follows: i. 25% of the Common Shares to be issued within 30 days following NMG MI 1’s receipt of a local commercial medical marihuana retail license from the city of Muskegon, MI and a state commercial medical marihuana retail license from the state of Michigan; ii. 25% of the Common Shares to be issued within 30 days following NMG MI 1 passing final inspections at the Leased premises regarding the commercial medical marihuana retail license and receiving its local operating permit allowing NMG MI 1 to begin medical marihuana operations at the premises; iii. 25% of the Common Shares to be issued within 30 days following NMG MI 1’s receipt of a local commercial adult-use marihuana retail license from the city of Muskegon, MI and a state commercial adultuse marihuana retail license from the state of Michigan; iv. 25% of the Common Shares to be issued within 30 days following NMG MI 1 passing final inspections at the Leased premises regarding the commercial adult-use marihuana retail license and receiving its local operating permit allowing NMG MI 1 to begin adult-use marihuana operations at the premises; At 31 July 2021, the Company accrued $75,000 for milestones (i) and (ii) above (Note 15). Upon NMG MI C1 receiving one or more Licenses, NMG MI C1 agrees to cause the Company to issue common shares (the “Common Shares”) having a value of up to $600,000 to River Street, with portions of the Common Shares to be issued upon the achievement of certain milestones as follows: i. US$200,000 of Common Shares to be issued within 30 days of NMG MI C1 receiving local and state commercial marihuana cultivation licenses; ii. US$200,000 of Common Shares to be issued within 30 days of passing final inspections at the premises with respect to cultivation and receiving local operating permit to begin commercial marihuana cultivation operations at the premises; iii. US$100,000 of Common Shares to be issued within 30 days of NMG MI C1 receiving local and state commercial marihuana retail licenses; and iv. US$100,000 of Common Shares to be issued within 30 days of passing final inspections at the premises with respect to retail operations and receiving local operating permit to begin commercial marihuana retail operations at the premises. At 31 July 2021, the Company accrued $200,000 for milestone (i) above (Note 15). Upon NMG MI P1 receiving one or more Licenses, NMG MI P1 agrees to cause the Company to issue common shares (the “Common Shares”) having a value of up to $400,000 to River Street, with portions of the Common Shares to be issued upon the achievement of certain milestones as follows: i. US$200,000 of Common Shares to be issued within 30 days of NMG MI P1 receiving local and state commercial marihuana processing licenses; and ii. US$200,000 of Common Shares to be issued within 30 days of passing final inspections at the premises with respect to processing and receiving local operating permit to begin commercial marihuana processing operations at the premises. At 31 July 2021, the Company accrued $200,000 for milestone (i) above (Note 15). The value of the Common Shares will be calculated based on the lesser of: (1) the closing market price on the respective milestone achievement date and (2) a ten percent discount to the twenty day volume weighted average price for the twenty days immediately prior to the respective milestone achievement date(s).

Investment Agreement

Investment Agreement	12 Months Ended
	Jul. 31, 2021
Segmented Information and Major Customers
20. Investment Agreement	20. Investment Agreement On 30 October 2018, the Company entered into the Investment Agreement with Australis Capital Inc. (“Australis”). Pursuant to the terms of the Investment Agreement, Australis will acquire (i) 16,000,000 units of the Company and (ii) CAD$1,600,000 principal amount 8% unsecured convertible debentures. Under the terms of the Investment Agreement, the parties agreed to negotiate in good faith a license agreement pursuant to which the Company will grant Australis an exclusive and assignable license to use the Body and Mind brand outside of the United States of America on commercially reasonable terms. In addition, the Company was to enter into a commercial advisory agreement with Australis Capital (Nevada) Inc. (“Australis Nevada”), a wholly-owned subsidiary of Australis, pursuant to which Australis Nevada will provide advisory and consulting services to the Company at $10,000per month for a term ending on the date that is the earlier of: (i) five years following the closing of the transactions contemplated by the Investment Agreement, and (ii) the date Australis no longer holds 10% or more of the issued and outstanding Common Shares (Note 23). Subject to certain exceptions, Australis will be entitled to maintain its’ pro rata interest in the Company until such time as it no longer holds 10% or more of the issued and outstanding Common Shares. Subject to applicable laws and the rules of the Canadian Securities Exchange (the “CSE”), for as long as Australis owns at least 10% of the issued and outstanding common shares, Australis will be entitled to nominate one director for election to the Board of Directors of the Company (the “Board”). If Australis exercises all of the warrants and converts all of the debentures purchased, Australis will be entitled to nominate a second director for election to the Board. On 2 November 2018, the Company executed the Investment Agreement and completed the sale of securities pursuant to the Investment Agreement. During the year ended 31 July 2021, the Company paid an advisory fee of $144,000 (2020 - $144,000).

Other Agreements

Other Agreements	12 Months Ended
	Jul. 31, 2021
21. Other Agreements	21. Other Agreements The Company and NMG Cathedral City (“NMG CC”) entered into a management and administrative services agreement (the "Management Agreement") with Satellites Dip, LLC, ("SD"), a licensed cannabis business conducting commercial cannabis activity within the state of California. The one-year Management Agreement commenced on 6 June 2019 and encompassed the following: a. Management Fee: NMG CC will be paid a management fee of 30% of Net Profits or $10,000 per month, whichever is greater; b. Brand Licensing: NMG CC shall work to broker commercial arrangements between SD and third-party cannabis brand owners whereby SD licenses commercial cannabis brands from third parties in connection with SD's commercial cannabis activity in exchange for a license fee; c. Equipment and Capital: NMG CC shall furnish all equipment and machinery necessary for SD's manufacturing of the Branded Products. Any equipment provided by NMG CC to SD shall be owned by NMG CC in its entirety and, subject to SD's approval of the terms, leased to SD pursuant to an Equipment Lease Agreement entered into between NMG CC and SD, dated 6 June 2019; and d. Loan: The Parties have entered into a certain secured loan agreement dated 6 June 2019 whereby NMG CC has loaned SD $250,000 (the "Loan") to be used solely in connection with SD's commercial cannabis activity. The Loan shall be due and payable on 6 June 2020 (the "Maturity Date") and shall bear interest at a rate of 12% per annum which shall be accrued, compounded quarterly and payable on the Maturity Date. The Loan is secured by a security interest in and to all of SD's assets. On 30 November 2019, NMG CC entered into a settlement and release agreement (the “Settlement Agreement”) with SD whereby NMG CC and SD agreed to terminate the Management Agreement and to enter into a mutual release of any and all claims related to the Management Agreement, subject to the terms of the Settlement Agreement. As of 30 November 2019, SD owed NMG CC management fees (the “Monies Owed”) under the Management Agreement. In consideration of NMG CC’s discharge of the Monies Owed, SD has agreed to pay NMG CC one-hundred percent (100%) of all proceeds received from the sale of all or any part of its inventory (the “Inventory”) as of 1 November 2019. Pursuant to the Settlement Agreement, SD shall provide monthly updates of the remaining Inventory until the Inventory has been fully exhausted. NMG CC will determine the sale price for any item in Inventory subject to the Settlement Agreement. Brand Director Agreement On 30 November 2019, NMG CC entered into a brand director agreement (the “Brand Director Agreement”) with SD. Pursuant to the Brand Director Agreement, SD has engaged NMG CC to provide certain advisory and brand director services in connection with SD’s manufacture of Company-branded products, as well as certain other products (the “Managed Products”) as agreed to by NMGCC (the “Brand Director Services”). The initial term of the Brand Director Agreement is six months and the parties may renew the Brand Director Agreement for successive three-month renewal periods. The Brand Director Services include: (a) managing SD’s production of the Managed Products; (b) payment of a reimbursement fee to SD equal to the amount of direct costs and direct taxes applicable to the Managed Products; (c) managing inventory of the Managed Products; and (d) directing SD to enter into distribution agreements and sale agreements with third-party commercial cannabis licensees for the distribution and sale of the Managed Products in accordance with applicable law. Pursuant to the Brand Director Agreement, NMG CC will pay a monthly fee (the “Contribution Fee”) of $5,000 to SD. In connection with the Brand Director Agreement, as partial repayment for the principal and interest accrued under a certain loan agreement (the “Loan Agreement”) between NMG CC and SD dated 6 June 2019, SD waives payment of the Contribution Fee for the first five (5) months of the Brand Direction Agreement. In consideration for the Brand Director Services, SD (as the “Licensee”) has agreed to pay NMG CC (in its capacity as the “Brand Director”) a brand director fee for each calendar month during the term of the Brand Director Agreement, whereby Licensee shall pay to Brand Director a fee to be calculated as follows: (x) net revenue for a single calendar month, multiplied by, (y) seventy-five percent (75%); (z) plus any fees to be paid to NMG CC in connection with the equipment lease agreement (the “Equipment Lease Agreement”) dated 6 June 2019 (the “Equipment Lease Fee”) added to the product of (x) and (y), the (q) total amount shall be the fee paid to NMG CC. If the net revenue, minus the product of (x) and (y) is less than the Equipment Lease Fee in any given month, the difference shall carry over to the subsequent month, to be added to that month’s Equipment Lease Fee, or the difference may be paid by Licensee at its sole option. The Brand Director Agreement was terminated on 30 April 2021. Brand License Agreement On 30 November 2019, DEP entered into a brand license agreement (the “License Agreement”) with SD. Pursuant to the License Agreement, DEP granted SD a non-exclusive, non-transferable, and non-sub-licensable right (the “License”) to use certain licensed marks in connection with or on licensed products, solely in connection with SD’s commercial cannabis activity in California. In consideration for the License, SD will pay DEP a monthly fee equal to $100, payable on a quarterly basis. During the term of the License Agreement, SD must remain in compliance with all state and local cannabis rules and regulations in California, and maintain valid commercial cannabis licenses. SD will follow the guidance of DEP and only utilize packaging and labelling materials purchased from (or at the direction of) DEP. The License Agreement was in full force and effect for the duration of the Brand Director Agreement. As a result, the License Agreement was also terminated on 30 April 2021. Equipment Purchase Agreement On 30 November 2019, NMG CC and SD entered into an equipment purchase agreement (the “Equipment Purchase Agreement”) pursuant to which NMG CC agreed to purchase certain equipment (the “Equipment”) from SD. The aggregate purchase price for the Equipment is $235,685 and will be applied to the outstanding balance under the Loan Agreement. First Amendment to the Equipment Lease Agreement On 30 November 2019, NMG CC and SD entered into an amendment (the “First Amendment”) to the Equipment Lease Agreement. Pursuant to the First Amendment, NMG CC and SD amended (i) the term of the Equipment Lease Agreement to be coterminous with the Brand Director Agreement; and (ii) to update the equipment being leased pursuant to the Equipment Lease Agreement and to update the monthly rental rate for the equipment being leased. Release & Satisfaction of Loan Agreement On 30 November 2019, NMG CC and SD entered into a release and satisfaction of loan agreement (the “Release Agreement”). Pursuant to the Release Agreement, NMG CC agreed that all indebtedness of SD to NMG CC arising from the Loan Agreement (and promissory note issued in connection with the Loan Agreement) is hereby satisfied and discharged in full. The release is granted based on SD’s obligations and duties pursuant to the Equipment Purchase Agreement and its five (5) month waiver of the Contribution Fee under the Brand Director Agreement. For the year ended 31 July 2020, the Company recorded a loss of $331,743 related to the Settlement Agreement with SD as follows: Total amount settled $ 590,328 Future proceeds from Inventory 90,315 Write-off of accounts receivable (92,415 ) Credit towards future Contribution Fee 25,000 Production equipment acquired 235,685 Loss from the settlement $ 331,743

Income taxes

Income taxes	12 Months Ended
	Jul. 31, 2021
Income taxes
22. Income taxes	22. Income Taxes A reconciliation of income taxes at statutory rates with the reported taxes for the years ended 31 July 2021 and 2020 is as follows: The (benefit) expense for income taxes consists of the following: 2021 2020 Current: Federal $ 2,281,497 $ 1,428,797 State 99,322 9,040 2,380,819 1,437,838 Deferred: Federal (214,352 ) (1,303,670 ) State 242 - (214,110 ) (1,303,670 ) Total expense for income taxes $ 2,166,709 $ 134,168 Section 280E of the Internal Revenue Code (“IRC”) prohibits businesses engaged in the trafficking of Schedule I or Schedule II controlled substances from deducting normal business expenses, such as payroll and rent, from gross income (revenue less cost of goods sold). Section 280E was originally intended to penalize criminal market operators, but because cannabis remains a Schedule I controlled substance for U.S. Federal purposes, the Internal Revenue Service (the “IRS”) has subsequently applied Section 280E to state-legal cannabis businesses. Cannabis businesses operating in states that align their tax codes with the IRC are also unable to deduct normal business expenses from their state taxes. The nondeductible expenses shown in the effective rate reconciliation above is comprised primarily of the impact of applying Section 280E to the Company’s businesses that are involved in selling cannabis, along with other typical non-deductible expenses such as lobbying expenses. 2021 2020 Net loss for the year before income tax $ (190,248 ) $ (4,464,221 ) Federal and state income tax rates 21.00 % 21.00 % Expected income tax recovery 39,951 (937,486 ) IRC 280E disallowance 1,935,581 941,288 Stock options 243,829 268,439 Impairment of consolidated investment 176,816 - Non-consolidated income - 54,147 Other permanent differences (82,301 ) 15,757 Change in estimates and others - 1,193,750 Opening deferred tax adjustments (284,621 ) (1,251,727 ) Change in tax rates 7,598 - Change in benefit not recognized 129,856 (150,000 ) Total income tax expense $ 2,166,709 $ 134,168 The significant components of the Company's deferred income tax assets and liabilities are as follows: As at 31 July 2021 As at 31 July 2020 Deferred income tax asset Lease liabilities $ 123,208 $ 450,139 Investments 6,648 - Deferred tax allowance (129,856 ) - Deferred income tax liability Investment in NMG Ohio LLC - (71,418 ) Property and equipment – Non right-of-use (39,603 ) (186,298 ) Property and equipment – Right-of-use (101,404 ) (426,902 ) Brand and license (57,332 ) (177,971 ) Net deferred income tax liability $ (198,339 ) $ (412,450 ) Management assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit use of the existing deferred tax assets. A significant piece of objective negative evidence evaluated was the cumulative loss incurred over the three-year period ended 31 July 2021. Such objective evidence limits the ability to consider other subjective evidence, such as our projections for future growth. On the basis of this evaluation, as of 31 July 2021, a valuation allowance of $129,856 and as of 31 July 2020, a valuation allowance of $Nil has been recorded to recognize only the portion of the deferred tax asset that is more likely than not to be realized. The amount of the deferred tax asset considered realizable, however, could be adjusted if estimates of future taxable income during the carryforward period are reduced or increased or if objective negative evidence in the form of cumulative losses is no longer present and additional weight is given to subjective evidence such as our projections for growth. As a result of an “ownership change” within the meaning of Section 382(g) of the Internal Revenue Code of 1986, as amended, which occurred in the 31 July 2016 fiscal year, we are limited in our ability to utilize our net operating loss carryforwards and certain other built-in deductions in computing our taxable income beginning with the ownership change date. As a result, $2,450,364 of our net operating loss is limited. Following is a reconciliation of gross unrecognized tax benefits from uncertain tax positions, excluding the impact of penalties and interest. The tax accounting method was changed to the Farm Price method which allows a more granular assessment of each expense, for the cultivation and manufacturing operations only, to be applied and expensed as cost of goods, to determine net taxable income As at 31 July 2021 As at 31 July 2020 Beginning year balance $ 966,992 $ - Increase related to prior year tax positions - 406,508 Increase related to current year tax positions - 560,484 Ending year balance $ 966,992 $ 966,992 Of the $962,423 of gross unrecognized tax benefits from uncertain tax positions outstanding as of 31 July 2021, $Nil would affect our effective tax rate if recognized. Interest related to uncertain tax positions are required to be calculated, if applicable, and would be classified as “interest expense” in the two statements of operations. Penalties would be recognized as a component of “general and administrative expenses”. As of 31 July 2021, $24,750 of interest and $Nil penalties was reported and as of 31 July 2020, $13,979 interest and $Nil penalties were reported. Our U.S. federal income tax returns for 31 July 2018 through 2020 are open to review by the U.S. Internal Revenue Service. Our state income tax returns for 31 July 2018 through 2020 are open to review, depending on the respective statute of limitation in each state. As of 31 July 2021, we believe it is reasonably likely that, within the next twelve months, $Nil of the previously unrecognized tax benefits related to certain non-U.S. filing positions may be recognized due to the expirations of the statutes of limitations.

Subsequent Events

Subsequent Events	12 Months Ended
	Jul. 31, 2021
Subsequent Events
23. Subsequent Events	23. Subsequent Events On 6 August 2021, the Company entered into management agreements with each of NMG IL 1, LLC (“NMG IL 1”) and NMG IL 4, LLC (“NMG IL 4”) along with an option to indirectly acquire all of the membership interests in each of NMG IL 1 and NMG IL 4 pursuant to a convertible credit facility between our subsidiary, DEP and each of NMG IL 1 and NMG IL 4, and membership interest purchase agreements between DEP and the members of NMG IL 1 and NMG IL 4, subject to obtaining all required local and state regulatory authorization. Each of NMG IL 1 and NMG IL 4 have been identified in the Illinois Department of Financial and Professional Regulation (IDFPR) results of the Social Equity Justice Involved Lottery for 55 Conditional Adult-Use Cannabis Dispensary Licenses (Conditional Licenses) across the state. The certified results are from a lottery with a pool of applicants who scored 85 % or greater in their applications. NMG IL 1 and NMG IL 4 were drawn in BLS Region #5 (Chicago-Naperville-Elgin) where 36 conditional licenses are available. The applications are not tied to specified locations. In September 2021, Australis sold 9,900,000 of our restricted common shares in a private transaction which resulted in Australis’ beneficial ownership dropping below 10% of our outstanding common shares. As a result of Australis’ beneficial ownership falling below 10%, the Investment Agreement was terminated and monthly commercial advisory and consulting fees paid from the Company to Australis were terminated along with Australis’ entitlement to nominate a director to the board of directors of our Company (Note 20). On 17 September 2021, the Company closed the acquisition of the remaining 70% interest in NMG Ohio . The transaction included the transfer of a dispensary license for the Clubhouse Dispensary in Elyria, Ohio to our wholly owned subsidiary, NMG OH 1, LLC, which became effective on 4 September 2020. The transaction also included the final award of a production license which has now been transferred to our wholly owned subsidiary, NMG OH P1, LLC. As a result of the closing of this acquisition, the Company now indirectly own 100% of NMG Ohio. On 21 September 2021, the Company reported plans to enter the Michigan market with fully funded dispensary, cultivation and production facilities. The Company has leased a commercial building in Manistee, Michigan, with the intent of developing a cultivation facility with 50,000 square feet of canopy as well as a production facility. Architectural plans are complete for phase one which is planned for 20,000 square feet of canopy, 5,000 square feet of processing and 5,000 square feet of multi-use and office space. The second phase of development is planned for 30,000 square feet of canopy. The Company, through a wholly owned Michigan subsidiary, have received local and state licensing for our first Michigan dispensary, located in Muskegon. This is a social equity license granted in a limited license jurisdiction. Architect plans are complete, hawse have received our building permit, and construction has started on the leased building. Our dispensary is on a main thoroughfare street with exceptional parking. On November 12, 2021 the Compensation Committee and Board of Directors of Body and Mind approved an Executive Bonus Program for FY2022 for the CEO, COO and CFO. The Board of Directors approved an incentive-based cash bonus program for CEO’s consulting company and for the COO of up to a maximum of $200,000 per CEO or COO based on the consolidated revenue performance of the Company for each quarter of the fiscal year ended July 31, 2022 compared to the prior quarter. Each of the CEO and COO could earn (i) $5,000 in cash for each 1% revenue growth over the prior quarter, and/or (ii) $10,000 in cash for each 1% Adjusted EBITDA growth over the prior quarter, all subject to a $50,000 maximum amount per executive that could be earned for each quarter of the fiscal year ended July 31, 2022. In addition, the Compensation Committee and the Board of Directors approved that they will consider a further discretionary cash bonus to the CEO’s consulting company and the COO at the fiscal year ended July 31, 2022, based on performance metrics of the Company over the course of the fiscal year ended July 31, 2022. Furthermore, on November 12, 2021, the Compensation Committee and the Board of Directors approved a cash bonus to be paid to the CFO’s consulting company up to a maximum of $40,000 based on the timing of the filing of Company’s periodic reports for the fiscal year ended July 31, 2022. The bonus consists of a quarterly bonus of $10,000 per quarter based on filing of the Company’s Form 10-Q’s and 10-K by the filing deadline, not including any extensions pursuant to Rule 12b-25 under the Exchange Act. Pursuant to certain licensing milestones being achieved under a lease agreement for a premises in Muskegon, Michigan and certain licensing and operational milestones being achieved under two lease agreements for a premises in Manistee, Michigan, on 21 September 2021, the Company issued 238,929 shares of common stock at a deemed price of CAD$0.3938 per share to one entity based on the terms and conditions of the certain lease agreement for the Muskegon, Michigan premises and issued an aggregate of 1,304,601 shares of common stock at a deemed price of CAD$0.3937 per share to another entity based on the terms and conditions of the two lease agreements for the Manistee, Michigan premises.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	12 Months Ended
	Jul. 31, 2021
Significant Accounting Policies
Reclassification
Basis of presentation	Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of current period financial statements. These reclassifications had no effect on the previously reported net loss. These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and are expressed in U.S. dollars. The Company’s fiscal year end is 31 July.
Amounts receivable	Amounts receivable represents amounts owed from customers for sale of medical and recreational cannabis and sales tax recoverable. Amounts are presented net of the allowance for doubtful accounts, which represents the Company’s best estimate of the amount of probable credit losses in the existing accounts receivable balance. The Company determines the allowance for doubtful accounts based on historical experience and current economic conditions. The Company reviews the adequacy of its allowance for doubtful accounts on a quarterly basis. As of 31 July 2021 and 2020, the Company has no allowance for doubtful accounts.
Revenue recognition	The Company recognizes revenue from product sales when our customers obtain control of our products. This determination is based on the customer specific terms of the arrangement for wholesale operations. Upon transfer of control, the Company has no further performance obligations. All retail sales are considered COD. Due to the nature of the Company’s revenue from contracts with customers, the Company does not have material contract assets or liabilities that fall under the scope of ASC 606. The Company’s revenues accounted for under ASC 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue streams. The sales prices are generally fixed and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration. See Note 17 for revenue disaggregation table.
Inventory	Inventory consists of raw material, work in progress (live plants and plants in the drying process), finished goods, and consumables. The Company values its raw material, finished goods and consumables at the lower of the actual costs or its current estimated market value less costs to sell. The Company values its work in progress at cost. The Company periodically reviews its inventory for obsolete and potentially impaired items. As of 31 July 2021 and 2020, the Company has no allowance for inventory obsolescence.
Property and equipment	Property and equipment are recorded at cost and are amortized over their estimated useful lives on a straight-line basis as follows: Office equipment 7 years Cultivation equipment 7 years Production equipment 7 years Kitchen equipment 7 years Vehicles 7 years Vault equipment 7 years Leasehold improvements shorter of useful life or the term of the lease
Intangible Assets	Intangible assets acquired from third parties are measured initially at fair value and either classified as indefinite life or finite life depending on their characteristics. Intangible assets with indefinite lives are tested for impairment at least annually and intangible assets with finite lives are reviewed for indicators of impairment at least annually. The Company’s brands and licenses acquired from NMG have indefinite lives; therefore no amortization is recognized. The Company’s brands and licenses acquired by NMG SD have a finite life of 10 years, brands and licenses acquired by NMG LB and NMG OH 1 have a finite life of 10 years, customer relationships acquired by NMG OH 1 have a finite life of five years and are amortized over these estimated useful lives on a straight-line basis.
Goodwill	Goodwill represents the excess of the aggregate purchase price paid over the fair value of the net assets acquired in our business combinations. Goodwill is not amortized and is tested for impairment at least annually or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Events or changes in circumstances that could trigger an impairment review include a significant adverse change in business climate, an adverse action or assessment by a regulator, unanticipated competition, a loss of key personnel, significant changes in the manner of our use of the acquired assets or the strategy for our overall business, significant negative industry or economic trends, or significant underperformance relative to expected historical or projected future results of operations. The Company has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying value, including goodwill. If, after assessing the totality of events or circumstances, the Company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, additional impairment testing is not required. The Company tests for goodwill impairment annually during its fourth quarter.
Income taxes	Deferred income taxes are reported for timing differences between items of income or expense reported in the consolidated financial statements and those reported for income tax purposes in accordance with ASC 740, “Income Taxes”, which requires the use of the asset/liability method of accounting for income taxes. Deferred income taxes and tax benefits are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases, and for tax losses and credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company provides for deferred taxes for the estimated future tax effects attributable to temporary differences and carry-forwards when realization is more likely than not.
Equity Method Investments	The Company utilizes the equity method when accounting for investments in which the Company is able to exercise significant influence, but does not hold controlling interest. Significant influence is generally presumed to exist when the Company owns between 20% to 50% of the investee. Under the equity method of accounting, the investee's financials are not consolidated within the Company's financial statements.
Basic and diluted net loss per share	The Company computes net income (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive. Potentially dilutive options of 9,855,000 and warrants of 17,215,284 existed at 31 July 2021. This figure does not include 3,200,000 warrants issued to the Agent pursuant to the Loan Agreement, which warrants are held in escrow by us and are to be released to the Agent if we draw on the Delayed Draw Term Loan by December 31, 2021, or cancelled if we do not draw on the Delayed Draw Term Loan. Each warrant, if released to the Agent, will entitle the holder to acquire one share of common stock at an exercise price of US$0.45 per share until July 19, 2025.
Comprehensive loss	ASC 220, “Comprehensive Income”, establishes standards for the reporting and display of comprehensive income/loss and its components in the consolidated financial statements. As of 31 July 2021 and 2020, the Company reported foreign currency translation adjustments as other comprehensive income or loss and included a schedule of comprehensive income/loss in the consolidated financial statements.
Foreign currency translation	The Company’s functional currency is the Canadian dollar and its reporting currency is in U.S. dollars. The Company’s subsidiaries have a functional currency in U.S. dollars. The consolidated financial statements of the Company are translated to U.S. dollars in accordance with ASC 830, “Foreign Currency Matters”. Exchange gains and losses on inter-company balances that form part of the net investment in foreign operations are included in other comprehensive income. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. The exchange rates used to translate Canadian dollar to U.S. dollar was 0.8024 for monetary assets and liabilities and 0.7855 as an average rate for transactions occurred during the year ended 31 July 2021. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the determination of net loss.
Stock based compensation	The Company estimates the fair value of each stock option award at the grant date by using the Black-Scholes Option Pricing Model. The fair value determined represents the cost for the award and is recognized over the required service period, generally defined as the vesting period. The Company’s accounting policy is to recognize forfeitures as they occur.
Fair value measurements	The Company accounts for certain assets and liabilities at fair value. The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. We categorize each of our fair value measurements in one of these three levels based on the lowest level input that is significant to the fair value measurement in its entirety. These levels are: · Level 1 – inputs are based upon unadjusted quoted prices for identical instruments in active markets. · Level 2 – inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques (e.g. the Black-Scholes model) for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based observable inputs including interest rate curves, credit spreads, foreign exchange rates, and forward and spot prices for currencies. · Level 3 – inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models. Our Level 3 assets and liabilities include investments in other private entities, and goodwill and intangible assets, when they are recorded at fair value due to an impairment charge. Unobservable inputs used in the models are significant to the fair values of the assets and liabilities. The Company measures equity investments without readily determinable fair values on a nonrecurring basis. The fair values of these investments are determined based on valuation techniques using the best information available, and may include quoted market prices, market comparables, and discounted cash flow projections. The Company’s convertible note receivable was measured at fair value (Note 6). Other current financial assets and current financial liabilities have fair values that approximate their carrying values.
Use of estimates and assumptions	The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenditures during the reporting period. Actual results could differ from these estimates.
Lease accounting	The Company adopted ASC 842, leases effective 1 August 2019 using a modified retrospective approach. Under ASC 842, leases are separated into two classifications: operating leases and financial leases. Lease classification under ASC 842 is relatively similar to ASC 840. For a lease to be classified as a finance lease, it must meet one of the five finance lease criteria: (1) transference of title/ownership to the lessee, (2) purchase option, (3) lease term for major part of the remaining economic life of the asset, (4) present value represents substantially all of the fair value of the asset, and (5) asset specialization. Any lease that does not meet these criteria is classified as an operating lease. ASC 842 requires all leases to be recognized on the Company’s balance sheet. Specifically, for operating leases, the Company recognize a right-of-use asset and a corresponding lease liability upon lease commitment.

Nature and Continuance of Ope_2

Nature and Continuance of Operations (Tables)	12 Months Ended
	Jul. 31, 2021
Nature and Continuance of Operations
Schedule of consolidation of entities and its ownership interest	Name Jurisdiction Ownership Date of acquisition or formation DEP Nevada Inc. (“DEP Nevada”) Nevada, USA 100 % 10 August 2017 Nevada Medical Group LLC (“NMG”) Nevada, USA 100 % 14 November 2017 NMG Long Beach LLC California, USA 100 % 18 December 2018 NMG Cathedral City LLC California, USA 100 % 4 January 2019 NMG San Diego LLC California, USA 60 % 30 January 2019 NMG OH 1, LLC Ohio, USA 100 % 30 January 2020 NMG MI 1, Inc. Michigan, USA 100 % 24 June 2021 NMG MI C1 Inc. Michigan, USA 100 % 24 June 2021 NMG MI P1 Inc. Michigan, USA 100 % 24 June 2021
Schedule of ownership interest by equity method investment in consolidation	Name Jurisdiction Ownership Date of acquisition or formation NMG Ohio LLC Ohio, USA 30 % 27 April 2017

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	12 Months Ended
	Jul. 31, 2021
Significant Accounting Policies
Schedule of property and equipment estimated useful lives	Office equipment 7 years Cultivation equipment 7 years Production equipment 7 years Kitchen equipment 7 years Vehicles 7 years Vault equipment 7 years Leasehold improvements shorter of useful life or the term of the lease

Financial Instruments (Tables)

Financial Instruments (Tables)	12 Months Ended
	Jul. 31, 2021
Financial Instruments
Schedule of financial assets at fair value	As of 31 July 2021 As of 31 July 2020 Financial assets at fair value Cash $ 7,374,194 $ 1,352,130 Convertible loan receivable 1,648,816 1,290,263 Total financial assets at fair value $ 9,023,010 $ 2,642,393

Inventory (Tables)

Inventory (Tables)	12 Months Ended
	Jul. 31, 2021
Inventory
Schedule of inventory	31 July 2021 31 July 2020 Work in progress $ 503,215 $ 211,621 Finished goods 1,547,493 959,939 Consumables 885,448 598,277 Total $ 2,936,156 $ 1,769,837

Investment in NMG Ohio LLC (Tab

Investment in NMG Ohio LLC (Tables)	12 Months Ended
	Jul. 31, 2021
Investment in NMG Ohio LLC (Tables)
Schedule of reconciliation and summarized financial information of Investment in NMG Ohio LLC	31 July 2021 31 July 2020 30% equity investment: Opening balance $ 531,185 $ 134,066 Equity-method investment change from earnings 13,219 397,119 Total equity investment in NMG Ohio 544,404 531,185 Acquisition of remaining 70% interest: Opening balance 2,630,055 2,630,055 Acquisition costs: Common shares issued to vendors at fair value 297,042 - Acquisition costs: Cash payments to vendors 393,750 - Foreign exchange 7,919 Total advances for remaining 70% acquisition of NMG Ohio 3,328,766 2,630,055 Impairment loss (58,382 ) Acquisition of The Clubhouse Dispensary (Note 11) (3,814,788 ) - Total investment in NMG Ohio $ - $ 3,161,240 Loan receivable (payable) to NMG Ohio Opening balance $ (466,495 ) $ 701,781 Advances provided to NMG Ohio 1,120,015 112,869 Advances received from NMG Ohio - (1,252,429 ) Foreign exchange 4,671 (28,716 ) Transferred to NMG OH 1 and eliminated on consolidation 233,088 - Loan receivable (payable) to NMG Ohio $ 891,279 $ (466,495 ) During the year ended 31 July 2021, the Company provided $891,279 to NMG Ohio related to build-out of production facility and license fees.

Investment in and advances to_2

Investment in and advances to GLDH (Tables)	12 Months Ended
	Jul. 31, 2021
Investment in and advances to GLDH (Tables)
Schedule of total investment in GLDH	31 July 2021 31 July 2020 Opening balance $ 8,910,854 $ 7,373,036 Share issuances - 4,092,175 Share payment reduction - (793,416 ) Interest income accrued on the Note 88,143 1,040,000 Advances for working capital 3,030 2,143,609 Lease Assignment Agreement payment - 750,000 Amount transferred to Property and Equipment - (1,431,585 ) Amount transferred to Brand and Licenses - (3,585,483 ) Expensed during the year (188,879 ) (501,862 ) Foreign exchange 99,585 (175,620 ) 8,912,733 8,910,854 Impairment loss (534,165 ) - Acquisition of ShowGrow Long Beach dispensary (Note 11) (8,378,568 ) - Ending balance $ - 8,910,854

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Jul. 31, 2021
Property and Equipment
Schedule of property and equipment	Office Equipment Cultivation Equipment Production Equipment Kitchen Equipment Vehicles Vault Equipment Leasehold Improvements Total Cost: Balance, 31 July 2020 $ 73,310 $ 478,187 $ 545,723 $ 51,108 $ 38,717 $ 2,172 $ 4,245,389 $ 5,434,606 Additions (disposals) 328,261 (12,077 ) 24,979 - - 8,163 810,410 1,159,736 Balance, 31 July 2021 401,571 466,110 570,702 51,108 38,717 10,335 5,055,799 6,594,342 Accumulated Depreciation: Balance, 31 July 2020 15,844 182,232 130,421 14,421 18,797 897 472,790 835,402 Depreciation 33,921 68,312 79,745 7,301 5,531 893 669,447 865,150 Balance, 31 July 2021 49,765 250,544 210,166 21,722 24,328 1,790 1,142,237 1,700,552 Net Book Value: At 31 July 2020 57,466 295,955 415,302 36,687 19,920 1,275 3,772,599 4,599,204 At 31 July 2021 $ 351,806 $ 215,566 $ 360,536 $ 29,386 $ 14,389 $ 8,545 $ 3,913,562 $ 4,893,790

Business Acquisition (Tables)

Business Acquisition (Tables)	12 Months Ended
	Jul. 31, 2021
Business Acquisition
Schedule of Pro Forma	The Clubhouse Dispensary NMG LB Revenue $ 6,643,561 $ 5,940,087 Net income $ 1,565,316 $ 283,569 Year ended 31 July 2020 As Reported Pro Forma (unaudited) Revenue 6,232,521 16,859,485 Net income (4,598,389 ) (4,238,491 )
Schedule of Purchase consideration	Purchase consideration $ 3,814,788 Assets acquired: Cash 257,462 Amounts receivable 510,367 Prepaid expenses 4,965 Inventory 178,898 Property and equipment 763,951 Licenses and customer relationships 2,710,000 Liabilities assumed: Trade payable and accrued liabilities (443,589 ) Net assets acquired 3,982,054 Bargain purchase (167,266 ) TOTAL $ 3,814,788 Purchase consideration $ 8,378,568 Assets acquired: Cash 65,340 Prepaid expenses 15,264 Inventory 177,930 Property and equipment 5,402 Loan receivable (Note 7) 239,834 Liabilities assumed: Trade payable and accrued liabilities (732,262 ) Income taxes payable (423,931 ) Loans payable (Note 14) (12,190 ) Net liabilities acquired (664,613 ) Brand and licenses 6,510,000 Goodwill 2,533,181 TOTAL $ 8,378,568

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets Net (Tables)	12 Months Ended
	Jul. 31, 2021
Goodwill and Intangible Assets Net
Schedule of Intangible assets	As of 31 July 2021 Gross carrying amount Weighted average life (years) Accumulated amortization Net carrying amount Intangible assets: Brand $ 247,000 - $ - $ 247,000 Licenses 20,718,508 10.0 (1,184,175 ) 19,534,333 Customer relationships 90,000 5.0 (16,265 ) 73,735 Total intangible assets $ 21,055,508 $ (1,200,440 ) $ 19,855,068 As of 31 July 2020 Gross carrying amount Weighted average life (years) Accumulated amortization Net carrying amount Intangible assets: Brand $ 247,000 - $ - $ 247,000 Licenses 11,588,508 10.0 (78,025 ) 11,510,483 Total intangible assets $ 11,835,508 $ (78,025 ) $ 11,757,483
Schedule of gross carrying amount of goodwill	Balance at July 31, 2020 $ 2,635,721 Increase due to acquisitions 2,533,181 Balance at July 31, 2021 $ 5,168,902
Schedule of The expected amortization of the intangible assets	2022 $ 1,199,162 2023 1,199,162 2024 1,199,162 2025 1,199,162 2026 1,199,162 Thereafter 5,687,258 $ 11,683,068

Related Party Balances and Tr_2

Related Party Balances and Transactions (Tables)	12 Months Ended
	Jul. 31, 2021
Related Party Balances and Transactions
Schedule of related party transactions	For the year ended 31 July 2021 For the year ended 31 July 2020 A company controlled by the President, Chief Executive Officer and a director Management fees $ 159,657 $ 154,439 A company controlled by the Chief Financial Officer and a director Management fees 109,487 91,594 A company controlled by a former director and former President of NMG Management fees 65,000 141,665 A company controlled by the Corporate Secretary Management fees 70,990 63,853 Consulting fees - 3,044 A company controlled by the former Chief Executive Officer and a former director Management fees - 9,224 $ 405,134 $ 463,819

Loan Payable (Tables)

Loan Payable (Tables)	12 Months Ended
	Jul. 31, 2021
Loan Payable
Schedule of the Black Scholes Option

Operating leases (Tables)

Operating leases (Tables)	12 Months Ended
	Jul. 31, 2021
Operating leases
Schedule of supplemental cash flow information related to leases	Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 536,985 Right-of-use assets obtaining in exchange for lease obligations: Operating leases $ 380,832 Weighted-average remaining lease term – operating leases 6.27 years Weighted-average discount rate – operating leases 12 %
Schedule of maturities of lease liabilities	Year Ending 31 July Operating Leases 2022 (1) $ 1,051,964 2023 596,273 2024 607,262 2025 617,942 2026 and thereafter 1,366,633 Total lease payments $ 4,240,074 Less imputed interest (1,155,134 ) Total $ 3,084,940 Less current portion (761,415 ) Long term portion 2,323,525

Capital Stock (Tables)

Capital Stock (Tables)	12 Months Ended
	Jul. 31, 2021
Capital Stock
Schedule of fair value assumptions for stock options granted	Expected life of the options 3.125 years Expected volatility 195 % Expected dividend yield 0 % Risk-free interest rate 1.28 % Expected life of the options 3.125 years Expected volatility 194 % Expected dividend yield 0 % Risk-free interest rate 1.37 % Expected life of the options 3.125 years Expected volatility 173 % Expected dividend yield 0 % Risk-free interest rate 1.43 % Expected life of the options 3.125 years Expected volatility 127 % Expected dividend yield 0 % Risk-free interest rate 1.11 % Expected life of the options 3.125 years Expected volatility 133 % Expected dividend yield 0 % Risk-free interest rate 0.32 % Expected life of the options 2.066 years Expected volatility 116 % Expected dividend yield 0 % Risk-free interest rate 0.25 % Expected life of the options 3.125 years Expected volatility 112 % Expected dividend yield 0 % Risk-free interest rate 0.49 % Expected life of the options 1.81 years Expected volatility 101 % Expected dividend yield 0 % Risk-free interest rate 0.51 %
Schedule of stock option activity
Schedule of warrants activity	Number of warrants Weighted average exercise price Outstanding at 31 July 2019 22,514,771 CAD$1.22 Exercised (165,715 ) CAD$0.73 Expired (9,933,772 ) CAD$0.89 Outstanding at 31 July 2020 12,415,284 CAD$1.49 Issued 4,800,000 USD$0.40 Outstanding at 31 July 2021 (1) 17,215,284 CAD$1.21
Schedule of number of warrants outstanding and exercisable	Number of warrants outstanding and exercisable Exercise price Expiry dates 11,780,134 CAD$ 1.50 17 May 2023 635,150 CAD$ 1.25 16 May 2023 4,800,000 USD$ 0.40 19 July 2025 17,215,284 CAD$ 1.21

Supplemental Disclosures with_2

Supplemental Disclosures with Respect to Cash Flows (Tables)	12 Months Ended
	Jul. 31, 2021
Supplemental Disclosures with Respect to Cash Flows
Schedule of supplemental disclosures with respect to cash flows	Year Ended 31 July 2021 2020 Cash paid during the year for interest $ - $ - Cash paid during the year for income taxes $ 582,152 $ 67,717

Other Agreements (Table)

Other Agreements (Table)	12 Months Ended
	Jul. 31, 2021
Other Agreements (Table)
Schedule of information related to the settlement agreement with SD	Total amount settled $ 590,328 Future proceeds from Inventory 90,315 Write-off of accounts receivable (92,415 ) Credit towards future Contribution Fee 25,000 Production equipment acquired 235,685 Loss from the settlement $ 331,743

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Jul. 31, 2021
Income taxes
Schedule of (benefit) expense for income taxes	2021 2020 Current: Federal $ 2,281,497 $ 1,428,797 State 99,322 9,040 2,380,819 1,437,838 Deferred: Federal (214,352 ) (1,303,670 ) State 242 - (214,110 ) (1,303,670 ) Total expense for income taxes $ 2,166,709 $ 134,168
Schedule of effective rate reconciliation	2021 2020 Net loss for the year before income tax $ (190,248 ) $ (4,464,221 ) Federal and state income tax rates 21.00 % 21.00 % Expected income tax recovery 39,951 (937,486 ) IRC 280E disallowance 1,935,581 941,288 Stock options 243,829 268,439 Impairment of consolidated investment 176,816 - Non-consolidated income - 54,147 Other permanent differences (82,301 ) 15,757 Change in estimates and others - 1,193,750 Opening deferred tax adjustments (284,621 ) (1,251,727 ) Change in tax rates 7,598 - Change in benefit not recognized 129,856 (150,000 ) Total income tax expense $ 2,166,709 $ 134,168
Schedule of deferred income tax assets and liabilities	As at 31 July 2021 As at 31 July 2020 Deferred income tax asset Lease liabilities $ 123,208 $ 450,139 Investments 6,648 - Deferred tax allowance (129,856 ) - Deferred income tax liability Investment in NMG Ohio LLC - (71,418 ) Property and equipment – Non right-of-use (39,603 ) (186,298 ) Property and equipment – Right-of-use (101,404 ) (426,902 ) Brand and license (57,332 ) (177,971 ) Net deferred income tax liability $ (198,339 ) $ (412,450 )
Schedule of reconciliation of gross unrecognized tax benefits from uncertain tax positions, excluding the impact of penalties and interest	As at 31 July 2021 As at 31 July 2020 Beginning year balance $ 966,992 $ - Increase related to prior year tax positions - 406,508 Increase related to current year tax positions - 560,484 Ending year balance $ 966,992 $ 966,992

Nature and Continuance of Ope_3

Nature and Continuance of Operations (Details)	12 Months Ended
	Jul. 31, 2021
DEP Nevada Inc
Date of acquisition or formation	10 August 2017
Ownership	100.00%
Jurisdiction	Nevada, USA
NMG MI 1, Inc
Ownership	100.00%
Jurisdiction	Michigan, USA
Nevada Medical Group LLC
Date of acquisition or formation	14 November 2017
Ownership	100.00%
Jurisdiction	Nevada, USA
NMG MI C1 Inc.
Date of acquisition or formation	24 June 2021
Ownership	100.00%
Jurisdiction	Michigan, USA
NMG Long Beach LLC
Date of acquisition or formation	18 December 2018
Ownership	100.00%
Jurisdiction	California, USA
NMG Cathedral City LLC
Date of acquisition or formation	4 January 2019
Ownership	100.00%
Jurisdiction	California, USA
NMG MI P1 Inc.
Date of acquisition or formation	24 June 2021
Ownership	100.00%
Jurisdiction	Michigan, USA
Nmg San Diego LLC
Date of acquisition or formation	30 January 2019
Ownership	60.00%
Jurisdiction	California, USA
NMG OH 1, LLC
Date of acquisition or formation	30 January 2020
Ownership	100.00%
Jurisdiction	Ohio, USA
NMG Ohio LLC
Date of acquisition or formation	27 April 2017
Ownership	30.00%
Jurisdiction	Ohio, USA

Nature and Continuance of Ope_4

Nature and Continuance of Operations (Details Narrative)	12 Months Ended
	Jul. 31, 2021	May 31, 2004
State of incorporation	Delaware
Represents information related to Vocalscape, Inc.
Ownership		100.00%

Significant Accounting Polici_4

Significant Accounting Policies (Details)	12 Months Ended
	Jul. 31, 2021
Office Equipment [Member]
Estimated useful lives	7 years
Cultivation equipment [Member]
Estimated useful lives	7 years
Production Equipment [Member]
Estimated useful lives	7 years
Kitchen equipment [Member]
Estimated useful lives	7 years
Vehicles [Member]
Estimated useful lives	7 years
Vault equipment [Member]
Estimated useful lives	7 years
Leasehold Improvements [Member]
Estimated Useful Life	shorter of useful life or the term of the lease

Significant Accounting Polici_5

Significant Accounting Policies (Details Narrative)	12 Months Ended
	Jul. 31, 2021shares
Dilutive options and warrants existed	17,215,284
Brands and licenses acquired by NMG SD
Dilutive options and warrants existed	3,200,000
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	10 years
Brands and licenses acquired by NMG LB and NMG OH 1
Dilutive options and warrants existed	9,855,000
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	10 years

Financial Instruments (Details)

Financial Instruments (Details) - USD ($)	Jul. 31, 2021	Jul. 31, 2020
Financial Instruments
Cash	$ 7,374,194	$ 1,352,130
Convertible loan receivable	1,648,816	1,290,263
Total financial assets at fair value	$ 9,023,010	$ 2,642,393

Financial Instruments (Details

Financial Instruments (Details Narrative) - USD ($)	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Financial Instruments
Net cash flows from operations	$ 294,965	$ (2,310,164)
Working capital deficit	$ 7,852,848

Inventory (Details)

Inventory (Details) - USD ($)	Jul. 31, 2021	Jul. 31, 2020
Inventory
Work in progress	$ 503,215	$ 211,621
Finished goods	1,547,493	959,939
Consumables	885,448	598,277
Total	$ 2,936,156	$ 1,769,837

Convertible loan receivable (De

Convertible loan receivable (Details Narrative) - USD ($)	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Loan receivable	$ 1,648,816	$ 1,290,263
Accrued interest income	0	51,000
Interests receivable	$ 150,000	$ 78,000
CCG | Convertible Loan Agreement
Outstanding units percentage	40.00%
Proceeds from fund construction	$ 1,250,000
NMG [Member]
Management fee (per month)	$ 6,000
Percentage of monthly management fee	66.67%
Loan bears interest per month	$ 6,000

Loan receivable (Details Narrat

Loan receivable (Details Narrative)	Jul. 31, 2021USD ($)
Convertible loan receivable
Loan receivable	$ 239,834

Investment in NMG Ohio LLC (Det

Investment in NMG Ohio LLC (Details) - USD ($)	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
30% equity investment:
Opening balance	$ 531,185	$ 134,066
Equity-method investment change from earnings	13,219	397,119
Total equity investment in NMG Ohio	544,404	531,185
Loan receivable (payable) to NMG Ohio
Opening balance Loan	(466,495)	701,781
Advances provided to NMG Ohio	1,120,015	112,869
Advances received from NMG Ohio	0	(1,252,429)
Foreign exchange	4,671	(28,716)
Transferred to NMG OH 1 and eliminated on consolidation	233,088	0
Loan receivable (payable) to NMG Ohio	891,279	(466,495)
NMG Ohio LLC
30% equity investment:
Opening balance	2,630,055	2,630,055
Total equity investment in NMG Ohio		2,630,055
Loan receivable (payable) to NMG Ohio
Foreign exchange	7,919
Acquisition of remaining 70% interest:
Acquisition costs: Common shares issued to vendors at fair value	297,042	0
Acquisition costs: Cash payments to vendors	393,750	0
Total advances for remaining 70% acquisition of NMG Ohio	3,328,766	2,630,055
Impairment loss	(58,382)
Acquisition of The Clubhouse Dispensary (Note 11)	(3,814,788)	0
Total investment in NMG Ohio	$ 0	$ 3,161,240

Investment in NMG Ohio LLC (D_2

Investment in NMG Ohio LLC (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Jan. 31, 2019	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2019
Loan to NMG Ohio LLC		$ (891,279)	$ (112,869)
Net revenues		$ 26,900,869	$ 6,232,521
NMG Ohio LLC
Percentage of voting interest acquired	100.00%
Purchase of remaining ownership interest percentage	70.00%	70.00%
Consideration in cash to be paid for the acquisition of remaining interest	$ 1,575,000
Common stock shares issued				2,380,398
Share issue costs (in shares)	3,173,864
Common stock shares fair value				$ 1,448,805
Cash payments				$ 1,181,250
Remaining cash payments totaling		$ 393,750
Remaining issuance of common stock shares		793,466
Ownership percentage		30.00%
Net revenues		$ 534,971
Expenses		490,906
Net income		44,065
Equity pickup		$ 31,219

Investment in and advances to_3

Investment in and advances to GLDH (Details) - USD ($)	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Interest income accrued on the Note	$ 163,558	$ 1,119,503
Lease Assignment Agreement payment	536,985
Foreign exchange	4,671	(28,716)
GLDH
Opening balance	8,910,854	7,373,036
Share issuances		4,092,175
Share payment reduction	0	(793,416)
Interest income accrued on the Note	88,143	1,040,000
Advances for working capital	3,030	2,143,609
Lease Assignment Agreement payment	0	750,000
Amount transferred to Property and Equipment	0	(1,431,585)
Amount transferred to Brand and Licenses	0	(3,585,483)
Expensed during the year	(188,879)	(501,862)
Total investment	8,912,733	8,910,854
Foreign exchange	99,585	(175,620)
Impairment loss	(534,165)	0
Acquisition of ShowGrow Long Beach dispensary (Note 11)	(8,378,568)	0
Ending balance	$ 0	$ 8,910,854

Investment in and advances to_4

Investment in and advances to GLDH (Details Narrative) - USD ($)	Jul. 03, 2019	Nov. 28, 2018	Jul. 31, 2021	Nov. 04, 2019	Oct. 04, 2019	Sep. 12, 2019	Aug. 12, 2019
Warrants price per share			$ 0.57	$ 0.90	$ 0.90	$ 0.66	$ 0.66
GLDH
Interest rate per annum	12.00%
Loan, face amount	$ 200,000
David Barakett
Maximum consideration	$ 783,765
David Barakett | GLDH
Percentage of issued and outstanding common shares		100.00%
Common shares of VWAP		$ 0.7439
USD/CAD exchange rate		1.3296
Maximum number of common shares		11,255,899
Maximum consideration		$ 6,297,580
Senior secured convertible note		$ 5,200,000
Interest rate per annum		20.00%
David Barakett | GLDH | Eligibility condition three
Issuance of Earn Out shares		1,125,589
Issuance of Earn Out shares, percentage		10.00%
David Barakett | GLDH | Eligibility condition two
Issuance of Earn Out shares		4,502,360
Issuance of Earn Out shares, percentage		40.00%
Revenue		$ 3,300,000
David Barakett | GLDH | Eligibility condition one
Issuance of Earn Out shares		5,627,950
Issuance of Earn Out shares, percentage		50.00%
Australis Capital Inc. [Member] | Loan Agreement [Member]
USD/CAD exchange rate		0.7518
Loan, face amount		$ 4,000,000
Warrants price per share		$ 0.50

Investment in and advances to_5

Investment in and advances to GLDH (Details Narrative 1) - USD ($)	Jul. 03, 2019	Apr. 30, 2020	Nov. 28, 2018	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2019
David Barakett
Amount payable in common shares	$ 783,765
Payment of consulting and advisory services	200,000					$ 50,000
Payment of consulting and advisory services in subsequent to year end					$ 150,000
GLDH
Loan, face amount	$ 200,000
Interest rate per annum	12.00%
Forgive operating loan amount				$ 800,000
GLDH | David Barakett
Interest rate per annum			20.00%
Amount payable in common shares			$ 6,297,580
GLDH | Eligibility condition one
Amount to be paid in common shares	$ 1,500,000
Share price per share	$ 0.7439
Maximum number of common shares	2,681,006
GLDH | Eligibility condition two | David Barakett
Amount to be paid in common shares	$ 750,000
Share price per share	$ 0.7439
Maximum number of common shares	1,340,502
GLDH | Purchase Agreement
Investment purchase price	$ 6,700,000
Note to be applied towards the Purchase Price	$ 5,200,000
GLDH | Type of agreement
Interest rate per annum	5.00%
Amount payable in common shares	$ 750,000
Green Light District Management, LLC and GLDH (collectively referred to as "Licensor").
Licensor grants	2 years
Payment to Licensor of gross receipts from sales	3.00%
NMG San Diego LLC [Member]
Ownership percentage		60.00%		60.00%
Percentage of consolidated assets liabilities of subsidiary		100.00%
Percentage of disclosed non-controlling interest of subsidiary.		40.00%
Information about Subsidiary. | GLDH
Ownership percentage	100.00%
Information about subsidiary. | GLDH
Ownership percentage	60.00%

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Cost:
Balance	$ 5,434,606
Additions	1,159,736
Balance ending	6,594,342	$ 5,434,606
Accumulated Depreciation:
Balance AD	835,402
Depreciation	1,122,742
Balance AD ending	1,700,552	835,402
Net Book Value
Net Book Value:	4,893,790	4,599,204
Office Equipment [Member]
Cost:
Balance	73,310
Additions	328,261
Balance ending	401,571	73,310
Accumulated Depreciation:
Balance AD	15,844
Depreciation	33,921
Balance AD ending	49,765	15,844
Net Book Value
Net Book Value	351,806	57,466
Cultivation equipment [Member]
Cost:
Balance	478,187
Additions	12,077
Balance ending	466,110	478,187
Accumulated Depreciation:
Balance AD	182,232
Depreciation	68,312
Balance AD ending	250,544	182,232
Net Book Value
Net Book Value	215,566	295,955
Production Equipment [Member]
Cost:
Balance	545,723
Additions	24,989
Balance ending	570,702	545,723
Accumulated Depreciation:
Balance AD	130,421
Depreciation	79,745
Balance AD ending	210,166	130,421
Net Book Value
Net Book Value	14,389	19,920
Kitchen equipment [Member]
Cost:
Balance	51,108
Additions	0
Balance ending	51,108	51,108
Accumulated Depreciation:
Balance AD	14,421
Depreciation	7,301
Balance AD ending	21,722	14,421
Net Book Value
Net Book Value	29,386	36,687
Vehicles [Member]
Cost:
Balance	38,717
Additions	0
Balance ending	38,717	38,717
Accumulated Depreciation:
Balance AD	18,797
Depreciation	5,531
Balance AD ending	24,328	18,797
Net Book Value
Net Book Value	14,389	19,920
Vault equipment [Member]
Cost:
Balance	2,172
Additions	8,163
Balance ending	10,335	2,172
Accumulated Depreciation:
Balance AD	897
Depreciation	893
Balance AD ending	1,790	897
Net Book Value
Net Book Value	8,545	1,275
Leasehold Improvements [Member]
Cost:
Balance	4,245,389
Additions	810,410
Balance ending	5,055,799	4,245,389
Accumulated Depreciation:
Balance AD	472,790
Depreciation	669,447	229,485
Balance AD ending	1,142,237	472,790
Net Book Value
Net Book Value	3,913,562	3,772,599
Leasehold improvements, Balance	4,245,389	2,266,006
Right of use Assets [Member]
Cost:
Balance	2,257,055
Additions	662,800
Balance ending	2,919,855	2,257,055
Accumulated Depreciation:
Balance AD	123,240
Depreciation	257,592
Balance AD ending	380,832	123,240
Net Book Value
Net Book Value	2,539,023	$ 2,133,815
Leasehold improvements, Balance	$ 2,257,055

Property and Equipment (Detai_2

Property and Equipment (Details Narrative) - USD ($)	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Property and Equipment
General and Administrative Expenses	$ (11,402,882)	$ 112,025
Depreciation	$ 453,884	$ 266,080

Business Acquisition (Details)

Business Acquisition (Details) - USD ($)	Sep. 04, 2020	Aug. 28, 2020	Jul. 31, 2021	Jul. 31, 2020
Liabilities assumed:
Goodwill			$ 5,168,902	$ 2,635,721
The Clubhouse dispensary.
Purchase consideration (Note 8)	$ 3,814,788
Assets acquired:
Cash	257,462
Amounts receivable	510,367
Prepaid expenses	4,965
Inventory	178,898
Property and equipment	763,951
Licenses and customer relationships	2,710,000
Liabilities assumed:
Trade payable and accrued liabilities	(443,589)
Net assets acquired	3,982,052
Bargain purchase	(167,266)
TOTAL	$ 3,814,788
ShowGrow Long Beach dispensary.
Purchase consideration (Note 8)		$ 8,378,568
Assets acquired:
Cash		65,340
Amounts receivable		239,834
Prepaid expenses		15,264
Inventory		177,930
Property and equipment		5,402
Liabilities assumed:
Trade payable and accrued liabilities		(732,262)
Income taxes payable		(423,931)
Loans payable (Note 14)		(12,190)
Net liabilities acquired		(664,613)
Brand and licenses		6,510,000
Goodwill		2,533,181
TOTAL		$ 8,378,568

Business Acquisition (Details 1

Business Acquisition (Details 1) - USD ($)	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Revenue	$ 26,900,869	$ 6,232,521
Net income	(1,976,461)	$ (4,598,389)
NMG Long Beach LLC
Revenue	5,940,087
Net income	283,569
The Clubhouse dispensary.
Revenue	6,643,561
Net income	$ 1,565,316

Business Acquisition (Details 2

Business Acquisition (Details 2) - USD ($)	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Revenue	$ 26,900,869	$ 6,232,521
Net loss	(1,976,461)	(4,598,389)
Pro Forma [Member]
Revenue	27,972,106	16,859,485
Net loss	$ (1,913,199)	$ (4,238,491)

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Net (Details)	12 Months Ended
	Jul. 31, 2021USD ($)
Goodwill and Intangible Assets Net
Increase due to acquisitions	$ 2,533,181
Balance at July 31, 2020	2,635,721
Balance at July 31, 2021	$ 5,168,902

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets, Net (Details 1) - USD ($)	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Gross carrying amount	$ 21,055,508	$ 11,835,508
Accumulated amortization	(1,200,440)	(78,025)
Net carrying amount	19,855,068	11,757,483
Brand
Gross carrying amount	247,000	247,000
Accumulated amortization	0	0
Net carrying amount	247,000	247,000
Customer relationships
Gross carrying amount	90,000
Accumulated amortization	(16,265)
Net carrying amount	$ 73,735
Weighted average life (years)	5 years
Licenses
Gross carrying amount	$ 20,718,508	11,588,508
Accumulated amortization	(1,184,175)	(78,025)
Net carrying amount	$ 19,534,333	$ 11,510,483
Weighted average life (years)	10 years	10 years

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets, Net (Details 2)	Jul. 31, 2021USD ($)
Goodwill and Intangible Assets Net
2022	$ 1,199,162
2023	1,199,162
2024	1,199,162
2025	1,199,162
2026	1,881,172
Thereafter	5,687,258
Total	$ 11,683,068

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets, Net (Details Narrative) - USD ($)	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Goodwill and Intangible Assets Net
Amortization expenses	$ 1,457,550	$ 112,025
License fees	$ 7,925,000

Related Party Balances and Tr_3

Related Party Balances and Transactions (Details) - USD ($)	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Management fees	$ 405,134	$ 463,819
Consulting fees	537,760	565,472
President And Chief Executive Officer Member
Management fees	159,657	154,439
Chief Financial Officer And Director [Member]
Management fees	109,487	91,594
This member stands for former director and former president.
Management fees	65,000	141,665
This member stands for corporate secretary.
Management fees	70,990	63,853
Consulting fees	0	3,044
This member stands for corporate secretary former Chief Executive Officer and former director.
Management fees	$ 0	$ 9,224

Related Party Balances and Tr_4

Related Party Balances and Transactions (Details Narrative) - USD ($)	Jul. 31, 2021	Jul. 30, 2021	Jul. 31, 2020
Due to Related Parties, Current	$ 52,074		$ 52,937
Chief Executive Officer [Member]
Due to Related Parties, Current		$ 26,841	14,229
Chief Financial Officer One [Member]
Due to Related Parties, Current		18,914	7,833
This member stands for corporate secretary.
Due to Related Parties, Current		$ 6,319	5,875
This member stands for former director and former president.
Due to Related Parties, Current			$ 25,000

Loan Payable (Detail)

Loan Payable (Detail)	Apr. 05, 2021	Mar. 06, 2021	Jul. 07, 2020	Mar. 01, 2020	Oct. 01, 2019	Apr. 30, 2020	Jan. 23, 2020	Aug. 21, 2019	Jul. 31, 2021
Expected life of the options	1 year 9 months 21 days	3 years 1 month 15 days	2 years 24 days	3 years 1 month 15 days	3 years 1 month 15 days	3 years 1 month 15 days	3 years 1 month 15 days	3 years 1 month 15 days
Expected volatility	101.00%	112.00%	116.00%	127.00%	194.00%	133.00%	173.00%	195.00%
Expected dividend yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Risk-free interest rate	0.51%	0.00%	0.25%	1.11%	1.37%	0.32%	1.43%	1.28%
Warrants [Member]
Expected life of the options									4 years
Expected volatility									139.00%
Expected dividend yield									0.00%
Risk-free interest rate									0.55%

Loan Payable (Details Narrative

Loan Payable (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Jul. 19, 2021	Jul. 31, 2021	Jul. 31, 2020	Jul. 30, 2021
Warrant exercise price per share	$ 0.45
Legal fees and other fees		$ 973,594	$ 676,935
Warrants issued for services , amount		$ 1,037,146
Warrants issued for services , shares		4,800,000
Loans Payable, Current		$ 16,874	0	$ 16,874
Loans payable		$ 4,798,871	$ 0
FG Agency Lending LLC [Member]
Loans payable	$ 6,666,667
Advance loan payble	$ 6,000,000
Initial term loan description	The Company may draw upon the remaining face amount of $4,444,444 (the “Delayed Draw Term Loan”) upon providing a 30-day request to the Agent by 1 December 2021, whereby $4,000,000 will be advanced to the Company after applying the 10% origination discount
Rate of interest	13.00%
Warrants [Member]
Aggregate purchase common stock shares	8,000,000
Acquire common stock shares	4,800,000
Exercise price per share	$ 0.40
Escrowed shares	3,200,000
Term Loan mature	Jul. 19, 2025

Operating leases (Details)

Operating leases (Details)	12 Months Ended
	Jul. 31, 2021USD ($)
Operating leases
Operating cash flows from operating leases	$ 536,985
Operating leases	$ 380,832
Weighted-average discount rate - operating leases	12.00%
Weighted-average remaining lease term - operating leases	6 years 3 months 7 days

Operating leases (Details 1)

Operating leases (Details 1)	Jul. 31, 2021USD ($)
Operating leases
2021	$ 1,051,964
2022	596,273
2023	607,262
2024	617,942
2025 and thereafter	1,366,633
Total lease payments	4,240,074
Less imputed interest	1,155,134
Total	3,084,940
Less current portion	(761,415)
Long term portion	$ 2,323,525

Operating leases (Details Narra

Operating leases (Details Narrative) - USD ($)	Apr. 09, 2019	Aug. 02, 2018	Nov. 10, 2017	Aug. 28, 2020	Apr. 24, 2020	Jul. 31, 2021	Jul. 31, 2020
Lease expense						$ 577,272
Amortization of right-of-use assets included in General and Administrative Expenses						431,427
Amortization of right-of-use assets included in Cost of Sales						145,845
Operating lease, right-of-use asset and increase in lease liabilities						2,539,023	$ 2,133,815
Accounting Standards Update 2016-02 [Member]
Operating lease, right-of-use asset and increase in lease liabilities						$ 1,181,143
Discount rate for present value of future lease payments						12.00%
NMG [Member]
Description for lease option to extend	The Company has one option to extend the lease for an additional three-year term and an option to purchase the property at any point during the initial term	The rent is $4,000 per month increasing by 5% starting on 1 July 2021 and 1 July 2024.	The Company has four options to extend the lease and each option is for five years. The monthly rent was $12,500 plus common area expenses	The rent is $7,317 per month increasing by 3% every year until 10 January 2022.	The Company has three options to extend the lease and each option is for five years. The monthly rent is $15,450 per month increasing by 3% every year until 1 December 2022
Periodic rent payable, amount	$ 6,026	$ 4,000	$ 12,500	$ 7,317	$ 15,450
Operating lease, right-of-use asset and increase in lease liabilities						$ 662,800
Discount rate for present value of future lease payments						12.00%

Capital Stock (Details)

Capital Stock (Details)	Apr. 05, 2021	Mar. 06, 2021	Jul. 07, 2020	Mar. 01, 2020	Oct. 01, 2019	Apr. 30, 2020	Jan. 23, 2020	Aug. 21, 2019
Capital Stock
Expected life of the options	1 year 9 months 21 days	3 years 1 month 15 days	2 years 24 days	3 years 1 month 15 days	3 years 1 month 15 days	3 years 1 month 15 days	3 years 1 month 15 days	3 years 1 month 15 days
Expected volatility	101.00%	112.00%	116.00%	127.00%	194.00%	133.00%	173.00%	195.00%
Expected dividend yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Risk-free interest rate	0.51%	0.00%	0.25%	1.11%	1.37%	0.32%	1.43%	1.28%

Capital Stock (Details 1)

Capital Stock (Details 1)	Apr. 05, 2021$ / sharesshares	Mar. 06, 2021$ / sharesshares	Jul. 07, 2020$ / sharesshares	Oct. 01, 2019$ / sharesshares	Jul. 31, 2021CAD ($)shares	Jul. 31, 2021USD ($)$ / sharesshares	Jul. 31, 2020$ / shares	Jul. 31, 2020CAD ($)shares	Jul. 31, 2019$ / sharesshares
Option granted | shares			350,000
Weighted average exercise price, options granted			$ 0.88
Weighted average exercise price, options Cancelled			$ 0.88
Share-based Payment Arrangement, Option [Member]
Opening balance | shares					9,155,000	9,155,000		6,075,000
Option granted | shares	250,000	1,250,000		250,000	1,500,000	1,500,000		5,505,000
Option cancelled | shares					(100,000)	(100,000)		(2,425,000)
Option exercised | shares					(700,000)	(700,000)
Closing balance | shares					9,855,000	9,855,000		9,155,000	6,075,000
Number of options, Vested and fully exercisable | shares					7,055,000	7,055,000
Weighted average exercise price, opening balance						$ 0.70	$ 0.62
Weighted average exercise price, options granted	$ 0.65	$ 0.68		$ 0.93		0.61	0.80
Weighted average exercise price, options Cancelled						0.66	0.73
Weighted average exercise price, options Exercised						0.57
Weighted average exercise price, closing balance						0.71	$ 0.70		$ 0.62
Weighted average exercise price, Vested and fully exercisable						$ 0.70
Weighted average contractual term remaining (in years)					2 years 9 months 3 days	2 years 9 months 3 days		3 years 5 months 23 days	3 years 8 months 8 days
Weighted average contractual term remaining (in years), Vested and fully exercisable					2 years 3 months 18 days	2 years 3 months 18 days
Aggregate intrinsic value | $					$ 3,750			$ 1,675,750
Aggregate intrinsic value, Vested and fully exercisable | $						$ 2,812

Capital Stock (Details 2)

Capital Stock (Details 2) - $ / shares	Jul. 07, 2020	Jul. 31, 2021	Jul. 31, 2020
Issued	350,000
Warrants [Member]
Opening balance		12,415,284	22,514,771
Issued		4,800,000	(165,715)
Exercised			(9,933,772)
Closing balance		17,215,284	12,415,284
Weighted average exercise price, opening balance		$ 1.49	$ 1.22
Weighted average exercise price, Issued		0.40	0.73
Weighted average exercise price, Exercised			0.89
Weighted average exercise price, closing balance		$ 1.21	$ 1.49

Capital Stock (Details 3)

Capital Stock (Details 3) - $ / shares	12 Months Ended
	Jul. 31, 2021	Nov. 04, 2019	Oct. 04, 2019	Sep. 12, 2019	Aug. 12, 2019
Warrants price per share	$ 0.57	$ 0.90	$ 0.90	$ 0.66	$ 0.66
Range One [Member]
Number of warrants outstanding and exercisable	11,780,134
Warrants price per share	$ 1.50
Expiry dates	May 17, 2023
Range Two [Member]
Number of warrants outstanding and exercisable	635,150
Warrants price per share	$ 1.25
Expiry dates	May 16, 2023
Range Three [Member]
Number of warrants outstanding and exercisable	4,800,000
Warrants price per share	$ 0.40
Expiry dates	Jul. 19, 2025
Range Four [Member]
Number of warrants outstanding and exercisable	17,215,284
Warrants price per share	$ 1.21

Capital Stock (Details Narrativ

Capital Stock (Details Narrative) - USD ($)	Apr. 05, 2021	Mar. 06, 2021	Jul. 07, 2020	Jul. 02, 2020	Mar. 01, 2020	Nov. 04, 2019	Oct. 04, 2019	Oct. 01, 2019	Sep. 12, 2019	Aug. 12, 2019	Oct. 21, 2020	Apr. 30, 2020	Apr. 24, 2020	Jan. 23, 2020	Aug. 21, 2019	Jul. 31, 2021	Jul. 31, 2020	Nov. 14, 2020	May 14, 2020	Nov. 14, 2019
Capital stock, par value																$ 0.0001	$ 0.0001
Capital stock, shares authorized																900,000,000	900,000,000
Escrowed shares issued																2,681,006				70,500
Escrowed shares fair value																				$ 17,786
Number of warrants exercised						22,485	22,727		38,912	81,591						700,000
Stock options granted			350,000
Exercise price			$ 0.88
Proceeds from issuance of common stock									$ 19,405							$ 313,415	$ 90,839
Exercised						$ 15,291	$ 15,455			$ 40,688						$ 317,045
Common stock shares issued upon exercise of warrants						22,485	22,727		38,912	81,591						700,000
Warrants price per share						$ 0.90	$ 0.90		$ 0.66	$ 0.66						$ 0.57
Option cancelled			350,000
Exercise price of cancelled options			$ 0.88
Acquiring remaining interest, percentage																10.00%	10.00%
Australis Capital Inc. [Member]
Number of shares issued upon conversion of convertible debenture,value				$ 1,197,084
Number of shares issued upon conversion of convertible debenture				2,909,091
Stock Option One [Member]
Stock options granted			80,000
Exercise price			$ 0.57
Option cancelled			80,000
Exercise price of cancelled options			$ 0.57
Stock Option Two [Member]
Stock options granted			150,000
Exercise price			$ 0.61
Option cancelled			150,000
Exercise price of cancelled options			$ 0.57
Expiring on 21 August 2024 [Member]
Option cancelled																	950,000
Employee Stock Option One [Member]
Stock options granted					250,000							1,375,000		200,000
Exercise price					$ 0.41							$ 0.67		$ 0.88
Fair value of stock options					$ 56,287							$ 524,432		$ 68,645
Stock-based compensation																$ 28,055	$ 35,470
Employee Stock Option One [Member] | April 30, 2020 [Member]
Stock-based compensation																328,055	137,368
Employee Stock Option One [Member] | March 01, 2020 [Member]
Stock-based compensation																28,022	24,303
Employee Stock Option One [Member] | Tranches One [Member]
Stock option vesting period percentage					25.00%							25.00%		25.00%
Employee Stock Option One [Member] | Tranches Two [Member]
Stock option vesting period percentage					25.00%							25.00%		25.00%
Employee Stock Option One [Member] | Tranches Three [Member]
Stock option vesting period percentage					25.00%							25.00%		25.00%
Employee Stock Option One [Member] | Tranches Four [Member]
Stock option vesting period percentage					25.00%							25.00%		25.00%
Director [Member]
Stock options granted															2,850,000
Exercise price															$ 0.88
Stock-based compensation																$ 314,758	$ 977,571
Director [Member] | Tranches One [Member]
Stock option vesting period percentage															25.00%
Director [Member] | Tranches Two [Member]
Stock option vesting period percentage															25.00%
Director [Member] | Tranches Three [Member]
Stock option vesting period percentage															25.00%
Director [Member] | Tranches Four [Member]
Stock option vesting period percentage															25.00%
Share-based Payment Arrangement, Option [Member]
Stock options granted	250,000	1,250,000						250,000								1,500,000	5,505,000
Exercise price	$ 0.65	$ 0.68						$ 0.93								$ 0.61	$ 0.80
Exercise price of cancelled options																$ 0.66	$ 0.73
Fair value of stock options	$ 65,795	$ 456,211						$ 145,045							$ 1,373,856
Stock-based compensation																$ 42,840	$ 103,570
Share-based Payment Arrangement, Option [Member] | April 05, 2021 [Member]
Stock-based compensation																32,696
Share-based Payment Arrangement, Option [Member] | March 06, 2021 [Member]
Stock-based compensation																$ 194,729
Share-based Payment Arrangement, Option [Member] | Tranches One [Member]
Stock option vesting period percentage	25.00%	25.00%						25.00%
Share-based Payment Arrangement, Option [Member] | Tranches Two [Member]
Stock option vesting period percentage	25.00%	25.00%						25.00%
Share-based Payment Arrangement, Option [Member] | Tranches Three [Member]
Stock option vesting period percentage	25.00%	25.00%						25.00%
Share-based Payment Arrangement, Option [Member] | Tranches Four [Member]
Stock option vesting period percentage	25.00%	25.00%						25.00%
NMG [Member]
Escrowed shares issued																		70,500	70,500
Escrowed shares fair value																		$ 19,703	$ 15,760
Amount related to issued common shares										$ 2,752,782	$ 297,042		$ 1,342,175
Number of common shares issued										4,337,111	793,466		2,681,004
Acquiring remaining interest, percentage											70.00%

Segmented Information and Maj_2

Segmented Information and Major Customers (Details) - USD ($)	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Revenue	$ 26,900,869	$ 6,232,521
Operating income	(1,976,461)
Retail [Member]
Revenue	18,797,195
Operating income	(2,551,396)
Wholesale [Member]
Revenue	8,103,674
Operating income	(2,999,697)
All others [Member]
Revenue	0
Operating income	$ (7,527,554)

Segmented Information and Maj_3

Segmented Information and Major Customers (Details Narrative) - integer	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Segmented Information and Major Customers
Number of customers	0	0
Percentage of revenues from major customer	10.00%	10.00%

Supplemental Disclosures with_3

Supplemental Disclosures with Respect to Cash Flows (Details) - USD ($)	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Supplemental Disclosures with Respect to Cash Flows (Details)
Cash paid during the year for interest	$ 0	$ 0
Cash paid during the period for income taxes	$ 582,152	$ 67,717

Supplemental Disclosures with_4

Supplemental Disclosures with Respect to Cash Flows (Details Narrative) - USD ($)	Aug. 12, 2019	Oct. 21, 2020	Apr. 24, 2020	Nov. 30, 2019	Jul. 31, 2021	Jul. 31, 2020	Nov. 14, 2020	May 14, 2020	Nov. 14, 2019
Lease liabilities					$ 234,734
Aggregate receivable amount					1,544,957	$ 972,705
Production equipment					6,594,342	5,434,606
Net loss for the year					$ (1,976,461)	$ (4,598,389)
Escrowed shares issued					2,681,006				70,500
Escrowed shares fair value									$ 17,786
NMG [Member]
Amount related to issued common shares	$ 2,752,782	$ 297,042	$ 1,342,175
Number of common shares issued	4,337,111	793,466	2,681,004
Ownership percentage		70.00%
Escrowed shares issued							70,500	70,500
Escrowed shares fair value							$ 19,703	$ 15,760
Settlement Agreement with SD [Member]
Write-off of accounts receivable				$ (92,415)
Aggregate receivable amount				590,328
Accounts receivable from future sale of inventory				90,315
Future credits towards the contribution fee				25,000
Production equipment				235,685
Net loss for the year				$ 331,743

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - USD ($)	Feb. 10, 2020	Apr. 23, 2021	Oct. 30, 2018	Jul. 31, 2021
Periodic consulting fees payable			$ 10,000	$ 12,000
Term of contract				5 years
Increased in periodic payments of consulting fees				$ 16,500
Ownership percentage for increased in monthly services fee				10.00%
Frequency of periodic payment			monthly	monthly
Lease expense (Monthly)	$ 22,500	$ 5,000
Accrued expense				$ 200,000
Kendal [Member]
Common stock, shares issued during period				150,000
NMG MI P1 (i)
Lease expense (Monthly)	$ 7,500
Accrued expense				$ 200,000
Common stock, shares issued during period				400,000
Achievement description				US$200,000 of Common Shares to be issued within 30 days of NMG MI P1 receiving local and state commercial marihuana processing licenses
NMG MI C1 (i)
Accrued expense				$ 75,000
Common stock, shares issued during period				600,000
Achievement description				US$200,000 of Common Shares to be issued within 30 days of NMG MI C1 receiving local and state commercial marihuana cultivation licenses
NMG MI C1 (iii)
Achievement description				US$100,000 of Common Shares to be issued within 30 days of NMG MI C1 receiving local and state commercial marihuana retail licenses
NMG MI C1 (ii)
Achievement description				US$200,000 of Common Shares to be issued within 30 days of passing final inspections at the premises with respect to cultivation and receiving local operating permit to begin commercial marihuana cultivation operations at the premises
NMG MI C1 (iv)
Achievement description				US$100,000 of Common Shares to be issued within 30 days of passing final inspections at the premises with respect to retail operations and receiving local operating permit to begin commercial marihuana retail operations at the premises.
NMG MI P1 (ii)
Achievement description				US$200,000 of Common Shares to be issued within 30 days of passing final inspections at the premises with respect to processing and receiving local operating permit to begin commercial marihuana processing operations at the premises.

Investment Agreement (Details N

Investment Agreement (Details Narrative)	Jul. 02, 2020shares	Oct. 30, 2018CAD ($)shares	Jul. 31, 2021USD ($)	Jul. 31, 2020USD ($)	Oct. 30, 2018USD ($)
Advisory fee paid			$ 144,000	$ 144,000
Term of contract			5 years
Australis Capital Inc. [Member]
Number of units issued for unsecured convertible debentures | shares	2,909,091
Australis Capital (Nevada) Inc. | Commercial advisory agreement.
Periodic consulting fees payable per month					$ 10,000
Term of contract		5 years
Investment Agreement [Member] | Australis Capital Inc. [Member]
Number of units issued for unsecured convertible debentures | shares		16,000,000
Unsecured convertible debentures		$ 1,600,000
Interest rate per annum		8.00%			8.00%
Percentage of issued and outstanding common shares		10.00%			10.00%

Other Agreements (Details)

Other Agreements (Details) - USD ($)	1 Months Ended	12 Months Ended
	Nov. 30, 2019	Jul. 31, 2021	Jul. 31, 2020
Loss from the settlement		$ 0	$ 331,743
NMG Acquisition [Member] | Represents type of agreement member.
Total amount settled	$ 590,328
Future proceeds from Inventory	90,315
Write-off of accounts receivable	(92,415)
Credit towards future Contribution Fee	25,000
Production equipment acquired	235,685
Loss from the settlement	$ 331,743

Other Agreements (Details Narra

Other Agreements (Details Narrative) - USD ($)	Jun. 06, 2019	Nov. 30, 2019	Jul. 31, 2021	Jul. 31, 2020
Loss on settlement			$ 0	$ 331,743
Represents type of agreement member. | NMG Acquisition [Member]
Loss on settlement		$ 331,743
Equipment purchase price		235,685
Represents type of agreement member. | Represent the information about NMG.
Loss on settlement		331,743
Equipment purchase price		$ 235,685
Information about Settlement Agreement.
Percentage of proceeds received from the sale of inventory		100.00%
Information about Brand Director Agreement.
Contribution fee		$ 5,000
Information about License Agreement.
Monthly fee payable on a quarterly basis		$ 100
Management Agreement [Member] | Satellites Dip LLC [Member]
Management fee description	Management Fee: NMG CC will be paid a management fee of 30% of Net Profits or $10,000 per month, whichever is greater
Loan, face amount	$ 250,000
Debt due date	Jun. 6, 2019
Interest rate per annum	12.00%

Income Taxes (Details)

Income Taxes (Details) - USD ($)	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Current
Federal	$ 2,281,497	$ 1,428,797
State	99,322	9,040
Total Current	2,380,819	1,437,838
Deferred
Federal	(214,352)	(1,303,670)
State	242	0
Total Deferred	(214,110)	(1,303,670)
Total (benefit) expense for income taxes	$ 2,166,709	$ 134,168

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($)	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Income taxes
Net loss for the year before income tax	$ 190,248	$ (4,464,221)
Federal and state income tax rates	21.00%	21.00%
Expected income tax recovery	$ 39,951	$ (937,486)
IRC 280E disallowance	1,935,581	941,288
Stock options	243,829	268,439
Impairment of consolidated investment	592,747	0
Non-consolidated income		54,147
Other permanent differences	(82,301)	15,757
Change in estimates and others	0	1,193,750
Opening deferred tax adjustments	(284,621)	(1,251,727)
Change in tax rates	7,598	0
Change in benefit not recognized	129,856	(150,000)
Total income tax expense	$ 2,166,709	$ 134,168

Income Taxes (Details 2)

Income Taxes (Details 2) - USD ($)	Jul. 31, 2021	Jul. 31, 2020
Deferred income tax assets
Lease liabilities	$ 123,208	$ 450,139
Investments	6,648	0
Deferred tax allowance	(129,856)
Deferred income tax liability
Investment in NMG Ohio LLC	0	(71,418)
Property and equipment - Non right-of-use	(39,603)	(186,298)
Property and equipment - Right-of-use	(101,404)	(426,902)
Brand and License	(57,332)	(177,971)
Net deferred income tax liability	$ (198,339)	$ (412,450)

Income Taxes (Details 3)

Income Taxes (Details 3) - USD ($)	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Income taxes
Beginning year balance	$ 966,992
Increase related to prior year tax positions	0	$ 406,508
Increase related to current year tax positions	0	560,484
Ending year balance	$ 966,992	$ 966,992

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	12 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Income taxes
Deferred tax allowance		$ 129,856
Net operating loss		2,450,364
Gross unrecognized tax benefits from uncertain tax positions	$ 962,423
Unrecognized tax benefits effective tax rate	0
Unrecognized tax benefits interest	24,750	0
Unrecognized tax benefits penalties	$ 13,979	$ 0

Subsequent Event (Details Narra

Subsequent Event (Details Narrative)	Nov. 12, 2021USD ($)	Sep. 30, 2021shares	Aug. 16, 2021	Jul. 21, 2021	Sep. 21, 2021$ / sharesshares	Jul. 31, 2021$ / sharesshares	Jul. 17, 2021	Jul. 31, 2020$ / sharesshares
Common stock issued on achieving milestone | shares						109,077,778		107,513,812
Common stock, deemed price | $ / shares						$ 0.0001		$ 0.0001
CFO [Member]
Maximum incentive based cash bonus	$ 40,000
Cash	10,000
Board Of Directors [Member]
Maximum incentive based cash bonus	200,000
Cash	$ 5,000
Revenue growth	1.00%
CEO [Member]
Maximum incentive based cash bonus	$ 50,000
Cash	$ 10,000
Revenue growth	1.00%
Cultivation Facility [Member]
Area of property				50,000
Processing [Member]
Area of property				5,000
Canopy [Member]
Area of property				20,000
Office Space [Member]
Area of property				5,000
Second Phase Canopy [Member]
Area of property				30,000
NMG Ohio [Member]
Remaining ownership percentage							70.00%
ownership percentage after acquisition							100.00%
Subsequent Event [Member] | NMG IL 1 and NMG IL 4 [Member]
Lottery description			The certified results are from a lottery with a pool of applicants who scored 85 % or greater in their applications. NMG IL 1 and NMG IL 4 were
Subsequent Event [Member] | Australis [Member]
Restricted shares sold in private transaction | shares		9,900,000
Beneficial ownership falling, percentage		10.00%
Subsequent Event [Member] | Lease Agreement One [Member]
Common stock issued on achieving milestone | shares					238,929
Common stock, deemed price | $ / shares					$ 0.3938
Subsequent Event [Member] | Lease Agreement Two [Member]
Common stock issued on achieving milestone | shares					1,304,601
Common stock, deemed price | $ / shares					$ 0.3937